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ABSTRACT 
Matrix attachment regions (MARs) are DNA sequences that bind non-histone proteins 
in the chromatin scaffold and define discrete loops of DNA containing expressed genes in 
vivo. I have been studying the effects of flanidng transgenes with MARs on transgene 
expression levels in BMS maize callus. Three MAR elements, two from maize (Adhl 5' 
MAR and Mhal 5' MAR) and one from yeast (ARS1), have very different effects on 
transgene expression that bear no relation to their affinity for the nuclear matrix in vitro. 
The main effect of MARs is to prevent silencing of some (but not all) transgenes, at least 
when transgene silencing is operative. Additionally, MARs can influence the establish­
ment and heritability of transgene transcription states. During a period of five years, I 
found that the degree of transgene silencing in BMS cultures was progressively lost. The 
protective effect of MARs against transgene silencing was also progressively lost, suggest­
ing that trans-acting factors responsible for both effects were gradually lost as the cells 
aged. This observation is very similar to observations made in yeast where SIR proteins 
that are responsible for establishment and heritability of gene silencing are lost or ren­
dered functionally inactive as cells age. In yeast, SIR proteins also interact with the 
machinery responsible for non-homologous recombination (i.e. end-joining), and loss of 
SIR function is associated with reduced end-joining. Similarly, as transgene silencing was 
lost in BMS cultures, the levels of end-joining (as measured by stable transformation fre­
quencies) also decreased. Thus, factors involved in cellular aging, transgene silencing, 
end-joining, and the in vivo effects of matrix attachment regions in a multicellular eukary-
otic system may be inter-related, much as they are in yeast. 
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CHAPTER I. GENERAL INTRODUCTION 
1.1 Research Problem 
Targets for improvement in agriculturally important crops include disease and stress 
resistance genes or specialty traits that add value to the end-user. Until recently, new traits 
had to be introduced into elite parent lines through breeding programs that typically took 
many years. Plant transformation has shortened the time it takes to get a new trait into the 
desired genetic background. However, the introduction of transgenes into agriculturally 
imponant crop plants such as maize is still inefficient. Frequently, when a gene is trans­
ferred into maize or other plants by transformation, it is either silenced or subject to posi­
tion effects. This makes it necessary to produce large numbers of transformants to 
generate an event with the desired characteristics. Development of methods to prevent 
silencing or position effects would greatly reduce the numbers of transgenic events that 
need to be generated and screened, thereby improving transformation efficiency. 
1.2 Background and Significance 
Prior to the start of this work, there had been several reports, in which MAR elements 
flanking transgenes appeared to result in increased transgene expression, reduction of 
position effects or copy number dependent expression. The original observations were 
made in mouse and chicken cell lines (Stief et al., 1989; Klehr et al., 1991), but similar 
data were reported in plant cell lines shortly thereafter (Breyne et al., 1992; Allen et al., 
1993). Breyne et al. (1992) found that in transformed tobacco calli, a heterologous MAR 
derived from the human P-globin gene increased the average transgene expression level by 
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1.4-fold, but did not reduce position effects. In contrast, flanking transgenes with a plant 
MAR isolated from near the soybean lectin gene was able to reduce position effect varia­
tion in transgene expression levels by 60 percent. In another report, Allen et al. (1993) 
reported a 24-fold increase in transgene expression levels, but essentially no reductions in 
position effects. Thus, the effects of flanking transgenes with MARs appeared to be highly 
variable, and I suspected that more systematic study with larger sample numbers might 
help elucidate the underlying basis of this variability. Furthermore, I wanted to investigate 
the stability and predictability of MAR effects on transgene expression, to see if these 
interactions were genetic or epigenetic in nature. 
To investigate the effects of flanking transgenes with MARs in maize, I chose to use 
Black Mexican Sweet (BMS) com suspension cells, because they could be transformed at 
high frequency using particle gun bombardment. A yeast sequence (ARS1) reported to 
have MAR activity and effects on transgene expression in tobacco (Allen et al., 1993) was 
evaluated, alongside two MAR elements associated with endogenous maize genes (Avra-
movaand Bennetzen, 1993). 
1.3 Organization of Dissertation 
Chapter n is a literature review. This review covers research on MAR elements from 
the discovery of the nuclear matrix to more recent work examining the effects of MARs in 
transgenic studies. 
3 
Chapter III describes materials and methods used in this study. The primary methods 
used in this research study involved plasmid vector construction, BMS cell transformation, 
gene expression assays, and statistical analysis of data. 
Chapter IV describes and discusses the results of my work. This chapter is split into 
three sections. In the first section, I describe the effects of two MARs from maize and one 
from yeast on 35S::luciferase in BMS. I found that each MAR had different effects on 
transgene expression, that did not correlate with the binding affinity of each MAR for the 
nuclear matrix in vitro. By sampling large numbers of transformants, I also found that the 
distributions of transgene expression levels in BMS were bimodal and not normal. 
In the second section, the effects of flanking two different transgenes with Ac//i7 5' 
MAR elements were compared. Because this study was done over a period of 5 years I 
was able to evaluate whether the effects of MARs on transgene expression were stable 
over time in different subcultures of the same BMS cell line. At the start of this study, I 
found that the Adhl 5' MAR prevented silencing of 35S::luciferase transgenes, but not 
35S::Gt/S. As the BMS cells aged over time, the effects of \htAdhl 5' MAR were masked 
by a progressive loss of transgene silencing. Thus, the outcome of flanking transgenes by 
MARs is neither stable nor predictable, and their effects are epigenetic. Progressive loss of 
transgene silencing is also seen in aging yeast cells, and our observations suggest that this 
may be a general property of eukaryotic cells, as they get older. My data also indicate that 
the same MAR sequence can affect both the establishment and maintenance or heritability 
of stable transgene expression states. The latter effect was inferred from the novel discov­
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ery that derepression of silenced transgenes by a demethylating agent in vivo can be 
slowed by flanking MARs. 
The final section of chapter IV describes a variety of other experiments investigating 
the effects of MARs on transgene expression, e. g. whether the size of the loop flanked by 
MAR elements or linearization of plasmid-bome MAR-flanked cassettes in the vector 
backbone makes any difference. Other experiments determined the effects of linking the 
selectable marker and the reporter gene on the same vector and the influence of transgene 
copy number. Finally, I describe an experiment demonstrating that tht Adhl 5' MAR is in 
an open chromatin conformation in vivo. 
In chapter V, I summarize the results of all of my experiments concerning the effects of 
MAR elements on transgene expression in maize cells and make some general conclusions 
about the epigenetic effects of flanking transgenes with MARs. 
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CHAPTER II. LITERATURE REVIEW 
Matrix attachment regions (MARs) are DNA sequences that bind to the proteinaceous 
network inside the nucleus called the nuclear matrix. MAR elements are commonly found 
flanking the 5' and 3' ends of genes (Table I), and are characteristic features of chromatin 
from eukaryotes as diverse as single-celled yeast to complex multicellular organisms, such 
as humans and maize (Amati and Gasser, 1988; Sykes et al., 1988; Avramova and Ben­
netzen, 1993). MARs are thought to be involved in maintaining chromatin in either an 
open active state or a compacted inactive state, and in insulating chromosomal domains 
from the regulatory elements of neighboring domains. Many models have been proposed 
for the action of DNA sequence elements that insulate genes from the effects of surround­
ing chromatin (Wolffe, 1994). In one class of models, the elements impair activation of a 
gene by blocking interaction of the promoter with enhancers or transcription factors out­
side of its domain. In the other class of models, the transcriptional activity is maintained 
by the element blocking the diffusion or assembly of repressive chromatin proteins. 
Matrix attachment regions were originally divided into two groups of elements based 
on the way they were isolated. Those isolated by high salt extraction were called matrix 
attachment regions (MARs) and those isolated by lithium diiodosalicylate (LIS) were 
called scaffold attachment regions (SARs). Since it has been shown that both extraction 
methods give residual structures that bind the same DNA regions (e. g. Avramova and 
Bennetzen, 1993), many authors now consider MARs and SARs equivalent, and the MAR 
terminology is most frequently used. Throughout the rest of this thesis, DNA sequences 
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Table 1. Identified MAR Elements 
Gene Region Organism Reference 
HSP70 5' Drosophila (Mirkovitch et al., 1984) 
K-immunoglobulin J-C intron mouse (Cockerill and Garrard, 1986) 
fiishi-tarazu 5 ' & 3 '  Drosophila (Gasser and Laemmli, 1986a) 
Sgs-4 5 ' & 3 '  Drosophila (Gasser and Laemmli, 1986a) 
alcohol dehydrogenase 5 ' & 3 '  Drosophila (Gasser and Laemmli, 1986a) 
ARSI 3' yeast (Amati and Gasser. 1988) 
interferon-/3 5 ' & 3 '  human (Bode and Maass, 1988) 
P-globin 5- murine (Greenstein, 1988) 
P-globin 5 ' & 3 '  human (Jarman and Higgs, 1988) 
lysozyme 5 ' & 3 '  chicken (Phi-Van and Stratling, 1988) 
HPRT Isc intron human (Sykesetal., 1988) 
apolipoprotein B 5 ' & 3 '  human (Levy and Fortier, 1989) 
a-globin 3' chicken (Farache et al., 1990) 
rb7-5A 3' tobacco (Halletal., 1991) 
plasiocyanin 3* pea (Slatteret al., 1991) 
lectin 5 ' & 3 '  soybean (Breyne et al., 1992) 
Adhl 5' maize (Avramova and Bennetzen, 1993) 
Gmhsp 17.6-L 3' soybean (Schoffl et al., 1993) 
ST-LSl 5 ' & 3 '  potato (Dietz et al., 1994) 
Mhal 5* maize (Jin and Bennetzen, 1994, this work) 
P-phaseolin 5 ' & 3 '  Phaseolus (van der Geest et al.. 1994) 
Adhl 3' maize (Avramova et al., 1995) 
Heat Shock Cognate 80 5 ' & 3 '  tomato (Chinn and Comai, 1996) 
plastocyanin 5'&3' Arabidopsis (van Drunen et al., 1997) 
that associate with matrix or scaffold proteins in vivo and in vitro will be referred to as 
MARs. 
2.1 The Nuclear Matrix 
The networic of proteins in the eukaryotic cell that form the nuclear matrix was first 
discovered following extraction of nuclei with high salt (Berezney and Coffey, 1974). The 
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residual structure defined as the matrix maintained the shape of the nucleus even after 
numerous chemical treatments. The matrix was composed of 98% protein, but also con­
tained some DNA and RNA. In a subsequent report, Berezney's group found that DNA 
replication appeared to initiate within the nuclear matrix (Berezney and Coffey, 1975). 
Proteins that have been associated with the nuclear matrix can be divided into three 
groups: structural proteins such as matrins (Belgrader et al., 1991), high-mobility group 
proteins (Zhao et al., 1993), and lamins (Luderus et al., 1994); regulatory proteins such as 
topoisomerase II (Cockerill and Garrard, 1986; Gasser et al., 1986), and replication 
machinery proteins (McCready et al., 1980); and proteins that bind unwound AT-rich DNA 
such as SATBl(Dickinson et al., 1992; Nakagomi et al., 1994; Liu et al., 1997), ARBP 
(for attachment region binding protein) (von Kries et al., 1991), and nucleolin (Dickinson 
and Kohwi-Shigematsu, 1995). 
In addition to Berezney's early work on interphase nuclei, Laemmli's group identified 
a non-histone protein structure responsible for the basic shape of metaphase chromosomes 
(Paulson and Laemmli, 1977). When histones were removed from metaphase chromo­
somes in vitro, loops of DNA anchored to the proteinaceous matrix were observed. Even­
tually, Laemmli's group proposed that attachment sites in interphase chromosomes may 
also be the attachment sites they observed in metaphase chromosomes (Gasser and Laem­
mli, 1987). In a study published a short time later, they reported that MARs, previously 
identified as binding to interphase nuclear protein preparations, specifically bound 
metaphase protein preparations as well (Mirkovitch et al., 1988). The relationship between 
the matrix anchoring loops of chromatin in metaphase chromosomes and the nuclear 
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Figure 1. Diagram of a chromatin loop. Loop size can vary from 5 kp to greater tlian 
100 kb. MAR elements bind to the proteinaceous nuclear matrix separating 
the active region from the surrounding heterochromatin. 
matrix of interphase nuclei then became a hotly contested area of research, which is still 
not completely resolved to this day. 
2.2 The Loop Model of Chromatin Structure 
Shortly after the discovery of chromatin loops, a model for chromatin organization 
was proposed (Laemmli et al., 1978; Marsden and Laemmli, 1979). The model invokes 
specific chromatin attachment sites spaced at regular intervals that organize and separate 
chromatin into discrete functional loops (Figure 1). Genes within each loop are thought to 
be insulated from the regulatory effects of heterochromatin or transcriptional enhancers 
and silencers in neighboring loops. A prediction of this model is diat transgenes flanked by 
MAR elements should also form a discrete loop upon integration, and function indepen­
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dent of the surrounding chromatin. Thus, MAR-flanked transgenes should be expressed in 
a position-independent, copy-number-dependent fashion. 
2.3 Identification and Isolation of Matrix Attacliment Regions 
The first MAR element described was a 657 bp fragment found in the cluster of Droso-
phila hsp70 heat-shock genes (Mirkovitch et al., 1984). This MAR was identified by 
developing a new milder method of extraction employing LIS that was less prone to the 
"sliding" of attachment points. Many more MAR elements have since been discovered 
from various organisms, including most recently, both monocotyledenous and dicotylede-
nous plants (Table 1). The ubiquitous nature of MAR elements as components of eukary-
otic chromatin indicates they are likely to play an important and fundamental role in 
nuclear architecture. 
Two basic methods are employed in the isolation of MAR elements. The first method 
determines whether a sequence is bound endogenously to the matrix, whereas the second 
method determines whether an exogenous DNA sequence can bind to an isolated nuclear 
matrix. The first method is useful for determining whether a sequence is really bound to 
the nuclear matrix in vivo. However, it is possible that sequences that are not initially 
bound to the matrix bind during the isolation process. Using the second method, many 
labs have shown that MAR sequences from one species can bind nuclear matrices from 
other species. 
For each of the two MAR assays, the first three steps are identical. The first step is to 
remove the histones either with 2 M sodium chloride (Berezney and Coffey, 1974), or with 
LIS (Mirkovitch et al., 1984). The second step is to digest away the DNA that is unassoci-
ated with the matrix using various restriction enzymes. The third step is to separate the 
matrices from the solublized DNA by centrifugation. The fourth step is where the two iso­
lation methods differ. In the endogenous assay, the supernatant and the pellet fraction are 
run on a gel (in separate lanes), along with a lane containing both the pelleted nuclear 
matrix and the solubilized DNA. The gel is then blotted and probed with labeled putative 
MAR fragments. The fragments that hybridize in the pellet lane and the combined lane are 
MARs. In the exogenous assay, the pelleted matrices are incubated with end-labeled frag­
ments and competitor DNA (frequently sheared £. coli DNA). The mixture is then sepa­
rated by centrifugation, run on a gel, and blotted. Bands that hybridize in the pellet lane 
are MAR elements. 
2.4 Properties of MAR Elements 
2.4.1 Physical properties 
MAR elements are typically 300-2000 bp in length and greater than 70 percent AT-
rich. By attaching to the nuclear matrix, they create loops of chromatin 5-200 kb long. 
Most MARs also contain many conserved AT-rich motifs (Laemmli et al., 1992). One of 
these motifs is the consensus topoisomerase II cleavage site (GTNWAYATTNAT-
NNR)(Gasser and Laemmli, 1986b; Gasser et al., 1986). When fragments containing this 
motif are concatemerized, they form a MAR with artificially high binding affinity for die 
nuclear matrix (von Kries et al., 1991; Girard et al., 1998). Although MARs often show 
poor sequence conservation, MAR binding is generally conserved across species (Mieike 
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et al., 1990; von Kries et al., 1991; Breyne et al., 1992). MAR sequences often have a high 
capacity for unwinding in vivo and may exist as partially single stranded regions (Bode et 
al., 1992; Dicidnson et al., 1992; Boulikas, 1995). Recently, Singh et al. (1997) wrote a 
computer program that uses these physical properties to identify putative MAR elements 
in DNA sequences. 
2.4.2 Genetic properties 
Four genetic properties of MARs have been summarized in a recent review (Holmes-
Davis and Comai, 1998). First, some MARs act as boundary elements by functionally 
insulating the chromatin they flank from the influences of surrounding chromatin. As 
boundary elements, MARs prevent the spread of heterochromatin and insulate genes from 
the effects of transcriptional enhancers or silencers in neighboring loops (Gasser and 
Laemmli, 1987; Geyer, 1997). Second, MAR elements can play a role in regulation of 
chromatin structure and affect gene expression more directly, e. g. by binding regulatory 
trans-acting factors or by disrupting proteins involved in chromatin condensation such as 
histone HI. Third, MARs may function as origins of replication (Berezney and Coffey, 
1975; Gasser, 1991). For example, some yeast origins of replication (including ARSl) 
have been identified as MAR elements and/or transcriptional silencers (Amati and Gasser, 
1988). The final role proposed for MAR elements is in mitotic chromosome organization, 
where they may be involved in chromosome folding and chromatin compaction (Marsden 
and Laemmli, 1979). 
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2.5 MAR Effects on Transgene Expression in Animal Systems 
The first indication that MARs might have an effect on transgene expression came 
from studies using the P-globin locus control region (LCR)(Grosveld et al., 1987). When 
the human P-globin gene was flanked with sequences that included the LCR and intro­
duced into transgenic mice, each transgenic animal expressed the human P-globin trans­
gene at levels equal to that of the endogenous mouse gene, regardless of the insertion site. 
However, the LCR was known to contain transcription factor binding sites and other 
sequences critical for P-globin gene regulation. In a later study, it was shown that the LCR 
regions that Grosveld et al. had used in their study included MAR elements (Jarman and 
Higgs, 1988). Flanking a neo transgene with the MAR element located at the 5' end of the 
P-globin gene conferred position-independent expression, when the polyoma virus 
enhancer was included in the transgene constructs (Yu et al., 1994). Interestingly, neither 
the polyoma virus enhancer nor the P-globin 5' MAR alone could reduce position effects 
(Yu et al., 1994). 
The first experiment specifically testing the effects of MARs on transgene expression 
used A-elements derived from flanking regions of the chicken lysozyme gene (Stief et al., 
1989). The 5' A-element increased transgene expression approximately 10-fold, indepen­
dent of its chromosomal position, when transformed into chicken promacrophages. Later, 
Stief et al. demonstrated that die chicken lysozyme MAR could also reduce position effect 
variation in transgene expression in a cell line of another species, specifically rat fibro­
blasts (Phi-Van et al., 1990). In another study, the mouse whey acidic protein was flanked 
with the chicken lysozyme MAR, and 11 out of 11 lines with MARs expressed the gene. 
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compared to 50% of the lines generated using transgenes without flanking A-elements 
(McKnight et al., 1992). In addition, 4 out of 5 of the lines analyzed showed proper regu­
lation of the gene. Finally, Klehr et al. (1991) showed that flanking transgenes with MAR 
elements from either animals or plants increased the average expression level of transfor-
mants in mouse cell lines, indicating that MARs could function across very wide species 
boundaries. 
Cell lines containing MAR flanked transgenes have also been found to exhibit higher 
levels of gene expression in the presence of sodium butyrate than cell lines containing 
transgenes without MARs (Klehr et al., 1992). Butyrate is a short fatty acid that can stim­
ulate gene expression by inhibiting histone deacetylases. Histone acetylation is associated 
with open chromatin and access to the transcription machinery. Since the enzymes 
involved in histone acetylation and deacetylation are thought to be components of the 
nuclear matrix (Hay and Candido, 1983; Hendzel et al., 1991), it is possible that flanking 
MAR elements can facilitate histone acetylation in the presence of butyrate (Klehr et al., 
1992). 
2.6 MAR Effects on Transgenes in Plant Systems 
Results of these early animal studies generally showed that MARs increase the aver­
age expression level of transgenes and decrease the variation in expression from transfor-
mant to transformant, although there are many inconsistencies apparent in different 
studies. These features are consistent with MARs having a boundary element function. 
However, results from the first experiments performed in plants varied considerably from 
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these early animal studies. In the first study where MAR elements were tested in plant 
cells, Breyne et al. (1992) found that flanking a transgene with a soybean MAR element 
decreased the average expression 2-fold, and that this also decreased the variability in 
expression. A human MAR had no effect on transgene expression in their tobacco cell 
lines. In contrast, Allen et al. (1993) found that a MAR from yeast that bound tobacco 
nuclear proteins could increase the average transgene expression level 24-fold. In another 
study using tobacco plants, Mlynarova et al. (1994) reported that flanking transgenes with 
the chicken lysozyme MAR element reduced position effects and resulted in copy number 
dependent transgene expression. The conclusions from each of these studies illustrate the 
variability of effects that MARs can have on transgene expression. 
More recent work done with MARs in plants has indicated that they generally can 
increase the average expression level among transformants, but relatively few studies have 
reported significantly decreased variation of transgene expression levels or copy number 
dependent expression (Table 2). 
2.7 Gene Silencing 
Most transgenic studies using MARs were done in the hopes of preventing gene 
silencing. Silencing has been studied extensively in both animals and plants. In plants, 
much of the focus has been primarily on homology dependent silencing of transgene 
(Matzke and Matzke, 1995; Jorgensen et al., 1996). Homology dependent silencing phe­
nomena can be classified into one of two types; transcriptional or post-transcriptional. 
Transcriptional silencing generally involves either multiple linked copies of a transgene at 
Table 2. Summary of transgenic studies using MAR elements (Holmes-Davis and Comai, 1998) 
Source of MAR 
IVansrorm-
ants per 
construct 
Cell type or 
organism 
Copy 
number 
Increase 
in level of 
expression 
Copy number 
dependent 
expression 
Reduction 
of position 
effects Reference 
human P-globin 40 mice 1 to 
>100 
none yes yes (Gro.sveld et al., 1987) 
chicken lysozyme 10-19 chicken pro-
macrophages 
1-90 10 fold yes yes (Stief et al., 1989) 
luinian inlerfenm-fi mouse L cells 20-30 fold (Klehretal., 1991) 
chickcn lysozyme 12-14 rai-2 flbroblasis 1-270 4.5 fold son of "dampened" (Phi-Van et al., 1990) 
mouse 
K-immunoglobulin 
mouse plama-
cytoma cells 
1 4 fold N/A no (Blasquezet al., 1989) 
Drosophilu hsp70 16-27 HeLa 20-40 fold no no (Poljak et al., 1994) 
human apolipoprolein B human and rat 
hepatoma cells 
1 200-fold N/A yes (Kulos and Foumier, 
1995) 
soybean lectin -60 tobacco calli N/D - 2 fold N/D yes (Breyneet al.. 1992) 
human ^-globin -60 tobacco calli N/D slight N/D none (Breyne et al., 1992) 
yeusl ARSl -30 tobacco calli 18-160 24-fold no slight (Allen et al., 1993) 
soybean Gmhsp 17.6-L 8-18 tobacco plants N/D 7-9 fold N/D no (SchSfn et al., 1993) 
chicken lysozyme 46-60 tobacco plants 1 to >3 3-7 fold no yes (Mlynarovaet al., 1994) 
P-phaseolin 4-20 tobacco plants 1-2 1.5 fold yes yes (van der Geest et al., 
1994) 
chickcn lysozyme >60 tobacco plants 1 to >3 2 fold no yes (MIynarova et al., 1995) 
tobacco rh7-5A 16-17 tobacco calli 1-31 140 fold no no (Allen et al., 1996) 
tomato HSC80 11-32 tomato plants 1-5 yes no unclear (Chinn and Comai, 1996) 
Phaseolus P-phaseolin 2-10 tobacco plants N/D yes N/D no (van der Geest and Hall, 
1997) 
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a single site, or alternatively, a transgene and a homologous "target" gene located else­
where in the genome (Matzke and Matzke, 1995). With this form of silencing, no tran­
scripts are initiated from any of the silenced gene copies. When one of the transgenes 
becomes silenced, which usually correlates with an increase in methylation of the gene, 
this copy can then act as a silencer for other copies of the gene, either in cis- or in trans-. 
This may be a system for silencing endogenous transposable elements (Henikoff and 
Matzke, 1997) 
Post-transcriptional homology dependent silencing (also called cosuppression (Napoli 
et al., 1990)) may be caused by a threshold mechanism which senses the level of homolo­
gous mRNAs in the cytoplasm and activates a process for silencing when that threshold is 
reached (Smith et al., 1994). Post-transcriptional silencing is distinguished from other 
forms of silencing by the presence and continuous re-initiation of transcripts correspond­
ing to silenced gene copies. Methylation may also be involved in this type of silencing 
(English et al., 1996), and it is generally thought that post-transcriptional silencing is a 
plant's defense mechanism for preventing expression and replication of RNA viruses 
(Baulcombe and English, 1996). Because most viruses cannot be transmitted through the 
germline, whereas transposons can, this may be why genes silenced by transcriptional 
mechanisms generally stay silent when transmitted through meiosis, whereas post-tran-
scriptionally silenced genes regain full activity following meiotic segregation of the trans-
gene responsible for silencing (Henikoff and Matzke, 1997). 
Silencing has also been extensively studied in Drosophila and yeast. In Drosophila, 
two boundary elements have been identified: the suppressor of Hairy wing (su[Hw])-bind-
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ing region found in gypsy retroelements and specialized chromatin sequences (scs/scs') 
found flanking the 87A7 hsp70 locus (Geyer, 1997). These elements can prevent the 
spread of heterochromatin and block enhancer function when placed between the 
enhancer and promoter (Holdridge and Dorsett, 1991; Geyer and Corces, 1992; Kellum 
and Schedl, 1992; Roseman et al., 1993; Galliano et al., 1995). Several proteins have been 
identified that are necessary for the function of these elements. For the su(Hw)-binding 
region, the su(Hw) and mod(mdg4) proteins are required and for the scs elements, bound­
ary element associated factor (BEAF) protein is required (Geyer, 1997). 
A mosaic type of gene silencing called position-effect variegation (PEV) has been 
studied using the eye color genes in Drosophila. This type of silencing is seen when an 
endogenous gene is placed near a region of heterochromatin through chromosomal rear­
rangement or when a transgene integrates within a region of heterochromatin. Henikoff 
(1996) has suggested a pairing-looping model to account for PEV silencing. In this model, 
pairing of a gene in a euchromatic region and a honiologous gene in a heterochromatic 
region draws the euchromatic gene away from factors required for expression. 
Studies in yeast have identified three stages of gene silencing; establishment, mainte­
nance, and heritability (Loo and Rine, 1995). For establishment of silencing, the yeast cell 
must pass through S phase (Miller and Nasmyth, 1984; Lustig, 1998). The factors 
involved in establishment of silencing during passage though S phase have not yet been 
identified, although candidates include the origin recognition complex (ORG) and chro­
matin assembly factor-1 (CAF-1) (Lustig, 1998). Maintenance and heritability of gene 
silencing were distinguished by the elimination of the HML silencer using site-specific 
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recombination in vivo (Holmes and Broach, 1996). After elimination of the silencer, the 
HML locus remained silent until the next round of cell division. However, after cell repli­
cation, repression of the HML locus was gradually lost. This indicated that the HML 
silencer was not required for the maintenance of silencing within the cell cycle, but was 
required for heritability of the repressed state. 
There are primarily three chromosomal regions where transcriptional silencing occurs 
in yeast; the telomeres and the HMR and HML loci. Although some of the factors involved 
in silencing at these regions differ, they all require the silent information regulators (Sir2p, 
Sir3p, and Sir4p) and histones H3 and H4 (Lustig, 1998). Recently, studies have found 
that SIR proteins also function in recombination and aging. Using two-hybrid analysis, 
Tsukamoto et al. (1997) found that Sir4p could interact with yeast Hdflp. Hdflp is the 
yeast homolog of a subunit of Ku, the mammalian protein complex involved with non­
homologous DNA double strand break repair (Tsukamoto et al., 1997). Mutational analy­
sis revealed that SIR2, SIR3 and SIR4 were also involved in end-joining in yeast. There is 
also a link between SIR proteins and aging: loss of sir2, sir3, or sir4 function decreases 
the life span of the yeast cells, whereas a gain-of-function mutation {SIR4-42) increases 
life-span (Kennedy et al., 1997). This group also discovered that SGSl, the yeast homolog 
of the gene that causes Werner's syndrome (a human disease that results in premature 
aging) is involved (Sinclair et al., 1997). Mutations at SGSl cause relocalization of Sir3p, 
which results in loss of telomeric gene silencing and decreases the lifespan of the cells. 
When I embarked on my dissertation project, I wished to address whether the inconsis­
tencies in transgenic studies using MARs (Table 2) could be resolved with a more system­
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atic study using larger sample numbers. Furthermore, I wanted to know if the 
inconsistency of MAR effects on transgene expression might be related to epigenetic phe­
nomena. My results clearly demonstrate the epigenetic nature of MAR effects on trans-
gene expression and parallel many of the observations linking silencing, end-joining and 
aging in yeast. Thus, I propose that the influence of MARs on transgene expression in 
maize cells may involve silencing proteins analogous to diose encoded by the yeast SIR 
genes. 
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CHAPTER III. MATERIALS AND METHODS 
3.1 Vector Construction 
Plasmid maps for all vectors used in this work are shown in Figure 2. The plasmids 
PHP264 (Figure 2A), PHP1528 (Figure 2B), PHP3528 (Figure 2C), PHP5438 
(Figure 2D), PHP5456 (Figure 2E), and PHP5459 (Figure 2F) were constructed at Pioneer 
Hi-Bred International, Inc. before I started this work. PHP264 consists of an enhanced 
CaMV35S promoter (bases -421 to -90 and -421 to +2, (Gardner et al., 1981)), a 79 bp 
fragment from the 5' leader sequence of tobacco mosaic virus (Gallic et al., 1987), the first 
intron of the maize Adhl-S gene (Dennis et al., 1984), the coding sequence of the GUS (P-
glucuronidase) gene (Jefferson et al., 1987), and the potato proteinase II {pinlf) gene 
(bases 2 to 310, (An et al., 1989)). PHP264 and all other plasmids in this work have pUC 
derived backbones. The vectors PHP 1528 and PHP3528 are similar to PHP264 except for 
the coding sequence. PHP 1528 contains the firefly luciferase gene (de Wet et al., 1987) 
and PHP3528 contains the BAR gene from Streptomyces hygroscopiciis (Thompson et al., 
1987). A 839 bp EcoRI to HindlM fragment region of ARS1 (Struhl et al., 1979) was mod­
ified via site-specific mutagenesis (Sambrook et al., 1989), so it contained a BatnUl site on 
the 3' end and a Notl site on the 5' end. This modified ARS 1 fragment was then inserted 
into PHP1528 at the 5' and 3' ends of the 35S:.iuciferase cassette respectively, using stan­
dard cloning procedures (Sambrook et al., 1989), to create PHP5438 (Figure 2D). 
PHP5456 (Figure 2E) was made by replacing the luciferase coding sequence with the BAR 
coding sequence, using unique sites in the promoter and terminator. The 5' region of the 
maize Adhl gene (Dennis et al., 1984) was supplied in a pUC vector by our 
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Figure 2. Plasmids used in this study. A-W are plasniids that were used in this study. 
Planning of plasmid construction was done on Gene Construction Kit (Textco) 
and VectorN^ (Informax, Inc.) for the Macintosh. Graphics were created by 
VectorNTI. 
22 
C) Not! (4953) 
Pvull (4850) 
Sea! (4035) 
CaMV 
CaMV 
0' 
Adh1 \vXron 1 
^-lactamase 
PHP3528 
4969 bp 
Pvull (2486) 
EcoR1(2306) 
•QQRV($d4) 
•Pstl(784) 
Sail (855) 
Hindlll(948) 
Clal (1163) 
Pvull (1413) 
BamH! (1422) 
Sail (1694) 
Pvull (1925) 
Sal! (1986) 
D) 
Nsil(2210) 
Pvull (55). 
AlwNI(7366) 
EcoRI (231) 
Bglll (832) 
PstI (865) 
Sea! (6406) 
CaMV 
p-lactamase 
CaMV 
PHP5438 \ 
7900 bp I 
Adhl'mVcon 1 / 
Luciferase 
Pvull (5591) 
Hindlll (5496) 
PstI (5288) 
Bglll (5255) 
Not! (4648) 
Nsil(4546) 
Sad (4320) 
EcoRI (4310) 
EcoRV (1773) 
sti (1873) 
'all(1944) 
indlll (2037) 
lal (2252) 
Pvull (2502) 
'BamH! (2511) 
Ncol(2518) 
EcoRI (3107) 
Clal (3885)^^"^°^^ 
Figure 2. continued 
23 
E) Pvull (55) 
AlwNI(6119) 
EcoRI(231) 
Bglll (832) 
Pstl (865) 
ssaLmm 
CaMV" 
p-lactamase 
CaMV 
PHP5456 
6653 bp 
Aahl intron 1 
Pvull (4344) 
Hindlll (4249) 
Pstl (4041) 
Bglll (4008) 
NotU3401) 
^QQRV(1773) 
Pstl (1873) 
Sail (1944) 
Hindlll (2037) 
Sail (3075) 
Pvull (2502) 
•BamHlf2511) 
Sail (2783) 
Pvull (3014) 
Bglll (3064) 
F) AIWNU9694) 
Scat f8734) 
Pvull (7919) 
Hindlll (7824) 
Pstl (7616) 
Bglll (7583) 
NotI (6976) 
Nsil (6874) 
Sad (6648) 
EcoRI (6638) 
Clal(6213) 
EcoRV (6186) 
EcoRI (5435) 
Ncotf4846) 
Pvull (55) EcoRI (231) 
Bglll (832) 
Pstl (865) 
fcoRV (1773) 
C a M V — / S a i l  ( 1 9 4 4 )  
Hindlll (2037) 
Clal (2252) 
'vull (2502) 
amHI(2511) 
Sail (2783) 
Pvull (3014) 
Bglll (3064) 
Sail (3075) 
Nsil (3299) 
NotI (3401) 
EcoRV (4101) 
Pstl (4201) 
Sail (4272) 
p-lactamase 
O' 
Adhi \u\.xon 1 
PHP5459 
10228 bp 
CaMV 
O- CaMV Luciferase 
AdhUnUon 1 
BamHl (4839) 
Pvull (4830) C|3| (4530) Hindlll (4365) 
Figure!, continued 
24 
G) Pvull (7967) PstI (777) 
Sea! (7152) 
AlwNI(6195) 
Pvull (5603) 
Xhol (5366) 
Sail (5360) 
Clal (5352) 
Hindlll (5345) 
EcoRV (5341) 
EcoRI (5333) 
PstI (5331) 
>40/7/5' MAR 
B-lactamase ... 
CaMV 
0' 
Adh1 \n\ron 1 
PHP6248 
8245 bp 
Luciferase 
AdhlS' MAR 
BamHI (4373) 
Not! f4354) 
Xmsl(779) 
EcoRV (1479) 
Xhol (1575) 
Sad (1576) 
Sail (1650) 
Hindlll (1743) 
Clal (1958) 
Pvull (2208) 
BamHI (2217) 
Nco! (2224) 
EcoRI (2813) 
EcoRV (3564) 
Clal (3591) 
. EcoRI (4016) 
W/a252/^Sacl (4026) 
H) Hindlll (6647) 
Sail (6554) 
S9QimS0} 
Clal (6862) 
Xhol (6479) 
EcoRV (6383) 
Xmal(5683) 
PstI (5681) 
Pvull (4626) 
Pvull (114) 
BamHI (123) 
Sail (395) 
Pvull (626) 
•Bam (676) /-"T bar 
O' Adh1 \n\ton\ 
Pinll 
AdhlS MAR 
CaMV 
CaMV PHP6344 
6998 bp 
Adh1S MAR 
P-lactamase 
Sea! (3811) 
Sail (687) 
'N$il(911} 
Not! (1013) 
BamHI (1032) 
PstI (1990) 
EcoRI(1992) 
EcoRV (2000) 
Hindlll (2004) 
Clal (2011) 
Sail (2019) 
Xhol (2025) 
AIWNU2854) P^ull (2262) 
Figure 2. continued 
25 
I )  Sea! (8124) Hindlll(400) PstI (416) 
Sail (418) 
Xhol(715) 
Bgill(869) 
AlwNI (7167) 
Pvull (6575) 
Xhol (6338) 
Xmal (6311) 
AlwNI (5880) 
Bglll (5632) 
Xhol (5478) 
Sail (5181) 
Pstl (5179) 
MhalS MAR 
Pinll 
PHP6486 
8630 bp 
Luciferase 
Adhi \r\\ron 1 MhalS MAR 
CaMV 
CaMV 
AlwNI (1117) 
Xmal (1548) 
Xhol (1575) 
'Notin594) 
\Nsil(17Q4) 
^Sacin930) 
EcoRI (1932) 
:coRI (3135) 
BamHlf3731) 
Pvull (3744) 
Hindlll (4205) 
Sail (4298) 
Xmal (5169) Bglll (4373) 
J )  Scal(6877) 
AlwNI (5920) 
Pvull (5328) 
Xhol (5091) 
Xmal (5064) 
AlwNI (4633) 
Bglll (4385) 
Xhol (4231) 
B-lactamase MhalS MAR 
Pinll 
PHP6487 
7383 bp 
BAR 
AdhlMron 1 MhalS MAR 
CaMV 
CaMV 
Pstl (3932) 
Xmal (3922) 
Hindlll (400) 
Pstl (416) 
Xhol (715) 
Bglll (869) 
AlwNI (1117) 
Xmal (1548) 
Xhol (1575) 
Not! (1594) 
Nsil(1704) 
Bglll (1931) 
Pvull (1985) 
BamHI(2484) 
Pvull (2497) 
Hindlll (2958) 
Bglll (3126) 
Figure 2. continued 
26 
K) AlwNI (10549) 
ssauassm 
ARS1 
CaMV 
_, . CaMV 
p-lactamase qi 
Adhl'mVon 1 
PHP6602 
11083 bp 
ARS1 
Adh1mX\on^ 
CaMV Luciferase 
-ARS1 
NotI (7831) 
Nsil (7729) 
Sad (7503) 
Clal (7068) 
EcoRV (7041) 
NCOUS701) 
BamHI (5694) 
EcoRV (1773) 
Clal (2252) 
amHI (2511) 
Nsil (3299) 
amHI (4243) 
NotI (4256) 
L) 
EcoRV (4956) 
Clal (5435) 
AlwNI (1) 
Seal (9384) 
Bglll (8233) 
NotI (7626) 
Nsil (7524) 
Sad (7298) 
Xhol (823) 
-Xhol (1664) 
Sad (1665) 
CaMV 
CaMV 
p-lactamase 0' 
Adhi \n\.XQn 1 
PHP7522 
10343 bp 
^ Pinll ^ 
ARS1 ' 
CaMV 
CaMV 
Adhl'mUonA n 
Luciferase 
Ncol (5496) 
BamHI (5489) 
BamHI (2306) 
Bglll (2859) 
Nsil (3094) 
Bglll (3791) 
BamHI (4038) 
NotI (4051) 
Figure 2. continued 
27 
M) AlwNI/9903} 
scsums) 
Sad (7852) 
NotI (7831) 
Nsil (7729) 
Sad (7503) 
Clal (7068) 
EcoRV (7041) 
CaMV 
CaMV 
0' 
Adhi \n\xor\ 1 
p-laclamase 
PHP7528 
10437 bp BA 
ARS1 7 
CaMV 
O'CaMV 
Luciferase 
Adhi \n\ron 1 
BamHI (5694) 
Clal (5435) 
Hindlll (5220) 
N) Pvull(8021) 
Sea! f7206) Adhi5' MAR 
CaMV 
^lactamase 
CaMV 
0' 
PHP7974 
8299 bp 
Adhi \n\xon 1 
AdhlZ' MAR 
AlwNI (6249) 
Pvull (5657) 
Xhol (5420) 
Sail (5414) 
Clal (5406) 
Hindlll (5399) 
EcoRV (5395) 
EcoRlf5387) 
PstI (5385) 
BamHI (4427) 
Not! (4408) 
Bglll (832) 
EcoRV (1773) 
Hindlll (2037) 
Clal (2252) 
BamHI (2511) 
Bglll (3064) 
Nsil (3299) 
Bglll (3996) 
Hindlll (4237) 
BamHI (4243) 
NotI (4256) 
EcoRV (4956) 
PstI (777) 
Xmal(779} 
EcoRV (1479) 
Xhol (1575) 
^9(;I(1576) 
Sail (1650) 
Hindlll (1743) 
Clal (1958) 
Pvull (2208) 
BamHI (2217) 
Nco! (2224) 
EcoRV (2783) 
EcoRV (3014) 
'AlwNl (3068) 
NsH (4306) 
Figure!, continued 
28 
0) 
EcoRV (7644) 
Xmal (7474) 
Clal (7210) 
Hindlll (6995) 
Sail (6902) 
Pstl(6831) 
EcoRI (6753) 
PstI (6751) 
Xmal (6741) 
Sail (6729) 
Xhol (6579)' 
Not! (6573) 
Sea! (5655) 
Ncol(8430) Notl(1) 
EcoRV (701) 
PstI (801) 
Sail (872) 
"^aMV 
Pinll CaMV / \ ; 
/
, o&mmethylase 0' 
Adhi \nUon 1 \ 
Adh1\r\\.xon 1 
PHP7576 
8756 bp 
4XERE 
Promoter 
'0' MALS#2 
p-lactamase Pinll 
• Hindlll (965) 
• Clal (1180) 
Ncol (1446) 
-PstI (1468) 
-Xhol (1670) 
-Clal (1718) 
•Sail (2033) 
.Xmal (2089) 
^AlwNI (2227) 
^Hindlll (2597) 
»AlwNI (2863) 
AlwNI (4698)' 
EcoRI (3926) 
Xmal (3599) 
EcoRI (3604) 
P) 
Clal (7650) 
Hindlll (7643), 
EcoRV (7639) 
EcoRI (7631) 
PstI (7629) 
Xmal (7619) 
BamHI (7613) 
Nsil (7229) 
Not! (6405) 
Nsil (6303) 
Sad (6077; 
EcoRI (6067) 
Clal (5642) 
EcoRV (5615) 
EcoRI (4864) 
Nco! (4275) 
Xhol (7664) Pvull(7901) 
Sail (7658) 
AlwNI (1) 
p-lactamase 
AdhlZ' MAR 
PHP8069 
8492 bp 
/lOft/SMAR 
CaMV 
CaMV Adhi intron 1 
Luciferase 
Pvull (1773) 
BamHI (4268) 
Pvull (4259) 
PstI (2828) 
Xmal (2830) 
EcoRV (3530) 
Xhol (3626) 
Sad (3627) 
Sail (3701) 
Hindlll (3794) 
Clal (4009) 
Figure 2. continued 
29 
Q) 
AlwNI (9113) 
Pvull(8521) 
Xhol (8284) 
Sail (8278) 
Clal (8270) 
Hindlll (8263) 
EcoRI (8251) 
Psll (8249) 
PstI (777) 
Pvull (10885) 
Adh15' MAR CaMV 
CaMV p-lactamase 
AdhlmXron 
PHP8119 
11163 bp 
Luciferase 
Pinll 
V 
Adh15' MAR 
lambda fragment EcoRI (6937) 
AlwNI (6390) 
Xmal (6217) 
Xmal (779) 
Xhol (1575) 
Sad (1576) 
Sail (1650) 
Hindlll (1743) 
Clal (1958) 
Pvull (2208) 
BamHI (2217) 
.Ncolf2224) 
EcoRI (2813) 
Clal (3591) 
EcoRI (4016) 
Sad (4026) 
Nsil(4?5S) 
AlwNI (5886) 
Clal (4743) 
Not! (4354) 
R) Sea! f8026) 
AlwNI 17069) 
BamHI (4373) 
Bglll (406) 
CaMV 
B-lactamase 0' 
Adhi \n\rQn 1 
PHP13327 
8532 bp 
Luciferase 
Adhlnixon 1 
CaMV 
CaMV 
EcoRI (6297) 
Nsil (6201) 
Sail (5977) 
Bglll (5966) 
Sail (5685) 
BamHI (5413) 
Clal (5154) 
Hindlll (4939) 
Sail (4846) 
PstI (4775) 
EcoRV (4675) NotI 13975) 
EcoRV (1100) 
PstI (1200) 
Sail (1271) 
Hindlll (1364) 
Clal (1579) 
BamHI (1838) 
Ncol(1845) 
EcoRI (2434) 
EcoRV (3185) 
Clal (3212) 
EcoRI (3637) 
Sad (3647) 
Nsil (3873) 
Figure 2. continued 
30 
S) 
Pvull (10971) 
Xhol (10734) 
Sail (10728) 
Hindlll (10713) 
EcoRI (10701) 
Psll (10699) 
EcoRI (9387) 
Pvull (13335) 
PstI (777) 
Adh15' MAR 
CaMV 
CaMV. . 
°'A 
Adh1\n\XQn 1 
Luciferase 
B-lactamase 
PHP13328 
13613 bp 
AdhIZ' MAR 
lambda fragment 
Xmal (8667) 
Xmal (779) 
Xhol (1575) 
Sac! (1576) 
Sail (1650) 
Hindlll (1743) 
Pvull (2208) 
BamHl (2217) 
NCQi(2224) 
EcoRI (2813) 
,EcoRI (4016) 
Sad (4026) 
'NsiU4252) 
'Not! (4354) 
Sad (4373) 
Xmal (4379) 
BamHl (4384) 
Sail (4396) 
PstI (4406) 
T) 
Sea! (7965) 
AlwNI(70Q8) 
Pvull (6416) 
Sad (6198) 
NotI (6177) 
Nsll (6163) 
Bglll(6153) 
BamHl (5085) 
NotI (5066) 
Nsll (4964) 
BamHl (6823) hindlll (4414) 
Pvull (M9) Bglll(406) 
BamHl (429) 
Q-lactamase 
MITES fragment 
o\Adh1S MAR 
CaMV 
PHP13394 
8471 bp CaMV 
Adhi Mxon 1 
Luciferase 
Bglll (1497) 
EcoRV (2191) 
Sad (4738) 
EcoRI (4728) 
Clal (4303) 
San (2362} 
Hindlll (2455) 
'Clal (2670) 
Pvull (2920) 
BamHl (2929) 
Ncol(2936) 
EcoRV (4276) 
EcoRI (3525) 
Figure 2. continued 
31 
U) Pvull (309) 
Scat (6718) 
Bglll (406) 
BamHI (429) 
B-lactamase 
MITES fragment 
of AdMS MAR 
CaMV' 
HP13395 
7224 bp 
CaMV 
/Icw/introni y 
Bglll (1497) 
AlwNI(5761) 
Pvull (5169) 
Sad (4951) 
NotI (4930) 
Nsil (4916) 
Bglll (4906) 
•coRV(2191) 
Pstl(2291) 
Sail (2362) 
BamHI (3838). 
NotI (3819) 
Nsil (3717)' 
Sail (3493) 
Clal(2670) 
Pvull (2920) 
BamHI (2929) 
Sail (3201) 
vull (3432) 
Bglll (3482) 
V) 
Sea! (7820) 
AlwNI(6863) 
Pvull (6271) 
Sad (6053) 
Nsil (6041) 
EcoRI (5170) 
EcoRV (4474) 
Pvull (530) 
Sail (675) 
,Clal(685) 
. HIndlll (690) 
-EcoRV (698) 
Non-MITES fragment 
o\Adh15' MAR 
PHP13396 
8254 bp 
Luciferase 
Adhl'mMon 1 CaMV' 
CaMV 
EcoRI (702) 
PstI (712) 
sil (1576) 
Bam (1578) 
'Not! (1595) 
Nsil (1705) 
acl (1931) 
EcoRI (1933) 
Clal (2360) 
EcoRV (2389) 
EcoRI (3136) 
Ncol(3725) 
BamHI(3732) 
PstI (4378) 
Sail (4299) 
Hindlll (4206) 
Pvull (3745) 
Clal (3993) 
Figure 2. continued 
32 
W) Pvull (530) Xhol (669) 
Sea! f6585) 
p-lactamase 
Non-MITES fragment 
of Adh15' MAR 
PHP13397 
7019 bp 
BAR 
Adhr\n\xQr\ 1 
O' CaMV 
CaMV 
Pvull (5036) 
Sad (4818) 
Nsll (4806) 
EcoRI (3935) 
PstI (3933) 
Xmal(3923) 
EcoRV (3227) 
Sal! (675) 
Clal (685) 
Hindlll (690) 
EcoRV (698) 
EcoRI (702) 
PstI (712) 
Nsil (1576) 
iglll (1578) 
Not! (1595) 
Nsil (1705) 
Sail (1921) 
Bglll (1932) 
Pvull (1986) 
Sail (2213) 
Pvull (2498) 
Clal (2746) 
Hindlll (2959) 
Sail (3052) 
Sad (3134) Xhol (3127) 
Figure 2. continued 
collaborators Zoya Avramova and Jeff Bennetzen at Purdue University. The 948 bp BatriHl 
to PstI fragment containing the Adhl 5' MAR (Avramova and Bennetzen, 1993) was 
cloned into Bluescript SK+ (Stratagene). The Mhal 5' MAR (-2562 to -1442 of Genbank 
entry U09989; (Jin and Bennetzen, 1994)) was also subcloned into pUCI9. Vectors con­
taining these MARs flanking luciferase or BAR (PHP6248, PHP6344, PHP6486, and 
PHP6487) (Figure 2G-J) were constructed by inserting the MARs into sites at the 5' or 3' 
end of PHP 1528 or PHP3528, as described for PHP5438 and PHP5456. PHP7974 was 
constructed by removing the luciferase coding region from PHP6248, using unique sites in 
\htAdhl intron and pinll terminator, and replacing it with the GUS gene from PHP264. 
PHP8069 was constructed by replacing the downstream MAR with the Adhl 3' MAR, 
identified as a 1189 bp Xbal fragment located 8 kb downstream of the Adhl gene by our 
collaborators Zoya Avramova and Jeff Bennetzen. PHP8119 was constructed by inserting 
a 2.9 kb BgUl to BamWl fragment from phage lambda (38815-41738) between the pinll 
terminator and the MAR. PHP 13328 was constructed by inserting a 5.3 kb BgUl to Hin-
i/IU fragment from phage lambda (38815-44141) between the pinll terminator and the 
MAR. PHP7576 was constructed by replacing the luciferase coding sequence of PHP5947 
(Roth et al., in prep.) with a 936 bp fragment of dam methylase (195-1131 of Genbank 
entry V00272; (Brooks et al., 1983)) and linking it in cis- to PHP 1528 with the luciferase 
sequence replaced by a 1921 bp fragment of a mutant Z mays acetohydroxyacid synthase 
coding sequence (605-2526 of Genbank entry X63554; (Fang et al., 1992)), which confers 
resistance to the herbicide chlorosulfuron (Fromm et al., 1990). 
Two copies of the region from -1201 to -680 of Adhl containing MITEs (Figure 31) 
were placed end to end in pCRscript (Stratagene) and inserted into the 5' and 3' ends of 
PHP 1528 and PHP3528 to construct PHP 13394 and PHP 13395. PHP 13396 and 
PHP 13397 were constructed similarly using two copies of the region from -680 to -243 of 
Adhl, that does not contain MITEs. 
3.2 Transformation Methods 
The BMS cell line was maintained continuously from 1993 to 1998 in Dave Somers's 
lab (University of Minnesota, Minneapolis-St. Paul). Several sub-lines were requested 
from the Somers lab over the course of this study, and were designated BMS-S, BMS-S3, 
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Figure 3. BMS use time-line. The original BMS line is maintained by Dave Somers lab 
at the University of Minnesota. Five requests for subcultures were made. Four 
of these subcultures were use for experiments in our lab. 
BMS-S4 and BMS-S5 (Figure 3). Table 3 summarizes the use of each of these cell lines 
through the course of my dissertation study. The lines were subcultured twice a week 
using 586 media (modified MS2-D media (Bittel et al., 1996)). Prior to transformation. 
Table 3. Summary of BMS subculture usage. 
Number of Number of Events 
BMS Line Time in Use Experiments Assayed 
BMS-S 6/93-4/94 4 229i 
BMS-S3 8/95-11/96 5 5009 
BMS-S4 2/97- 1/98 5 1326 
BMS-S5 1/98- 1/98 2 2685 
cells were prepared for bombardment essentially as described in Unger et al. (1993). The 
procedure was optimized for the BMS cell line through cooperation with Grace St. Clair at 
Pioneer Hi-Bred International., Inc. BMS cell lines were subcultured two days before 
shooting. One day before shooting, cells were placed in osmoticum (586 medium + 3% 
polyethylene glycol 8000) at a density of 200 mg cells/ml. Ten nanograms of reporter 
plasmid and selectable marker plasmid were precipitated onto 750 |ig of 1.8 jam tungsten 
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Figure 4. Copy number frequency distribution for non-selected transgenes in BMS was 
determined for a DNA dose of 3.33 ng DNA (equivalent amounts of non-
selected reporter and selectable marker) per bombardment. The predominant 
copy number is one per genome. Unpublished data was provided by B. 
Drummond, M. Ross, D. Bond, G. St. Clair and B. Bowen (Pioneer Hi-Bred 
International, Inc.) ? indicates poor resolution from Southern blot analysis. 
beads (General Electric), and each preparation was divided into six aliquots for bombard­
ment. Twenty nanograms total DNA was used for all experiments, except for treatments 
using PHP6602, PHP7522, PHP7528, PHP8119, PHP 13327, and PHP 13328. For these 
plasmids amounts equimolar to the control plasmid PHP 1528 were used. This DNA dose 
yields a majority of events that contain two or fewer copies of the transgene (Drummond 
et al., 1991 and unpublished data, see Figure 4). One half milliliter of cells were pipetted 
in a two centimeter circle onto sterile filter sets (consisting of a grade 391 filter (Whatman) 
on top, and a grade 363 filter (Whatman) beneath), premoistened with 750 pi of the same 
media used for osmoticum. Cells were bombarded with a PDSIOOO helium gun (BioRad) 
using a 1100 psi rupture disk. Immediately after bombardment, cells were removed by 
placing the top filter on solid 586 media containing 3% Gel-Rite without selection. Three 
days after bombardment, the cells were scraped off the filter, suspended in 4 ml of 586 liq­
uid media and aliquoted (I ml/plate) to four plates of 586 solid media containing the her­
bicide BASTA (AgrEvo, Wilmington, DE) at 3 mg/L. Stable transformants were recovered 
4-8 weeks after bombardment and were subcultured twice to confirm BASTA resistance. 
Events were assayed for luciferase (or GUS) expression 7 days after the second subcul­
ture. Expression levels were normalized to total protein levels using the method of Brad­
ford (1976) and reagents from Bio-Rad. 
For transient gene expression assays, BMS cell lines were subcultured 24 hours before 
bombardment and placed in osmoticum 4 hours prior to shooting. 100 mg of cells were 
plated onto filters. Ten |ag of the test luciferase constructs were mixed with 2 pg of 
PHP264 and precipitated onto l.O tungsten beads (GE or BioRad). Bombardments 
were done using a 600 psi rupture disc. 20 hours after bombardment, cells were harvested 
and assayed for luciferase and GUS expression. Gene expression levels were normalized 
by dividing luciferase expression measurements (in light units per ml) by GUS expression 
levels (in light units per |il) measured in an equivalent volume of extract. 
3.3 Gene Expression Assays and Data Analysis 
Luciferase assays were done essentially as described by the luminometer manufacturer 
(Analytical Luminescence Laboratory, 1992). 100 mg of sample callus tissue was ground 
in 300 |il of 0.1 M phosphate buffer, pH 7.8, and 1 mM DTT and 10% of the cleared 
extract was diluted with 200 of buffer in each assay. 100 |il of 1 mM luciferin was 
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added and light units were measured using a 10-sec. integration time on either a single-
well (Model 2010) or a multi-well luminometer (Model 96000) from Analytical Lumines­
cence Laboratories. The Gus Light kit from Tropix, Inc. was used to assay GUS expres­
sion for the transient assays. 1% of the sample extract was used, and light units were 
measured using a 5-sec. integration time on a single-well or multi-well luminometer, 
according to the manufacturer's recommended protocol. For stable transformants, light 
units were normalized to total soluble protein using the method of Bradford (1976) and 
reagents from Bio-Rad. 
Two different luminometers were used in this study. Most of the reported data was 
obtained with the single-well luminometer (Model 2010), but some experiments were 
assayed on the multi-well luminometer (Model 9600) which could read microtitre plates. 
Although both luminometers could reliably measure differences in luciferase expression 
between events, measurements obtained on one instrument could not be directly compared 
to the other because the conversion was not linear. This is because Model 2010 uses a pho­
ton counting method and Model 9600 measures resistance across a photometer (personal 
communication with Analytical Luminescence Laboratories). All transgenic events from 
BMS-S5 were measured on the multi-well luminometer and therefore could not be 
directly compared with the other cell lines in Chapter IV, section 2.2. Other experiments 
done on the multi-well luminometer include the Ix vs. lOOx DNA doses (Chapter IV, sec­
tion 2.4) and the experiments comparing linearized vectors (Chapter IV, section 3.2). 
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3.4 Statistical Analysis 
Statistical analysis of log-transformed data was done using JMP version 3.1.5 for the 
Macintosh, from the SAS Institute, Inc. To test for normality, I used the Shapiro-Wilk test 
for normality. The cumulative distribution function (cdf) was calculated with the following 
formula: 
k 
I 
CDF (point k)= where n = # events and k=l,2,3,...,n . 
I {LU/ug\ 
i=l 
3.5 S-Adenosyi-L-Homocysteine Treatments 
S-adenosyl-L-homocysteine (SAH) was added to media at 150 |iM (De Cabo et al., 
1994). Each transgenic cell-line treated with SAH was first assayed prior to treatment and 
then placed on plates containing SAH. Samples were taken at 48 hours and 10 days and 
assayed for luciferase or GUS expression. Trichostatin A (TSA) treatments were done sim­
ilar to SAH. TSA was added to 586 solid media from a lOOOx stock to a final concentra­
tion of 1.5 pM (Yoshida et al., 1995). Samples were left on treated media for 24 hours and 
then assayed. 
3.6 MethylaseMethylation Assay 
Transformation of the inducible cell line 5.2 (a transgenic BMS line expressing a mod­
ified estrogen receptor (Roth et al., in prep.)) was done the same as the previous transfor­
mations with the following modifications. A single plasmid was used, containing dam 
methylase under inducible control by the estrogen response elements and 35S::MALS 
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which conferred resistance to chiorsulfuron (PHP7576; Figure 20). Selection media fol­
lowing bombardment contained 3mg/L BASTA and 20 ppb chlorosulfuron (DuPont, 
Wilmington, DE). 
Dam methylase expression following induction by estradiol resulted in growth arrest 
(data not shown). To ascertain if the Adhl 5' MAR was methylated by dam in vivo, sus­
pension cultures of stable transformants were induced in liquid media containing 10 
of estradiol. After 48 hours of induction, genomic DNA was prepared using the CTAB 
extraction method. One to two grams of homogenized tissue were added to 9 ml of CTAB 
buffer (0.1 M Tris, pH 7.5,27.4 mM CTAB (hexadecyltrimethyl-ammonium bromide), 0.7 
M NaCl, 0.5 M EDTA, pH 7.5) and incubated at 65° C for 1 hour. The mixture was 
extracted twice with chloroform and precipitated. The precipitated DNA was "hooked" 
with a pasture pipette and dissolved in 100 mM Tris (pH 7.5), 10 mM EDTA (pH7.5), 0.7 
M NaCl by incubation at 60° C for 1 hour. The DNA was precipitated with two volumes of 
ethanol, rinsed in 76% ethanol and dissolved in TE (10 mM Tris (pH 7.6), 1 mM EDTA 
(pH 8.0)). 15 |ig DNA was digested with the appropriate enzyme (Dpnl, Dpnil, or Sau3A 
(New England Biolabs, Beverly, MA) and separated on a 1% agarose gel run overnight at 
1 V/cm. DNA was transferred to positive-charged nylon membrane (Boehringer Man­
nheim) using standard procedures (Sambrook et al., 1989). For Southern analysis, the 
Adhl 5' MAR was used as a probe. T7 and T3 PCR primers were used to amplify the 
Adhl 5' MAR from a Bluescript vector according to manufactures recommended proce­
dure for producing digoxigenin labeled probes (Boehringer Mannheim Corporation, 1995) 
using a dUTP:dTTP nucleotide ratio of 1:4. Soudiem analysis was completed using proto­
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cols outlined in the Genius System User's Guide (Boehringer Mannheim Corporation, 
1995). 
3.7 Nuclear Matrix Binding Assay 
Nuclear matrix binding assays were done by Dr. Zoya Avramova at Purdue University 
essentially as described (Avramova and Bennetzen, 1993). Matrices were isolated from 
0.5 A260 units of leaf nuclei. 50 ng of MAR containing plasmid, ARSl, AdhI 5' MAR or 
Mhal 5' MAR in pUCI9, was cut with HindllUEcoRl, HindllUNotl, or HindUl respec­
tively, to separate the MAR from the plasmid backbone. The DNA was random primed 
with ^-P and incubated with the isolated nuclear matrices. Varying concentrations of E. 
coli DNA (100 to 2500-fold molar excess) were used as competitor to prevent nonspecific 
binding (the A-T content of E. coli DNA is ~50%) and to compare the affinity of different 
DNA fragments for proteins in the matrix preparation. After the incubation, the 100 |j1 
reaction was placed on a centrifuge and the nuclei were pelletted. The supemate was dis­
carded and DNA that remained bound to the pelletted nuclear matrices was run on a gel, 
transferred to a nylon membrane and exposed to film. 
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CHAPTER IV. RESULTS AND DISCUSSION 
4.1 In Vitro Properties of Matrix Attachment Regions Do Not Correlate 
With Their In Vivo Ejects 
4.1.1 Affinity of MARs for maize nuclear matrix in vitro 
In this study, we used three MAR elements: yeast ARSl(Amati and Gasser, 1988), and 
two MARs from the 5' regions of maize Adhl and Mhal, respectively (Avramova and 
Bennetzen, 1993; Jin and Bennetzen, 1994). Figure 5 shows the results of binding assays 
with maize nuclear matrix preparations, performed as described in Section 3.7. For each 
MAR (M), the binding to the maize nuclear matrix was more specific than the binding of 
the vector (V) sequences included in each assay. The Mhal 5' MAR displayed the highest 
affinity for binding to the nuclear matrix, and the yeast ARS1 sequence bound less effi­
ciently than either of the maize MARs (Figure 5A and B). In the presence of a large excess 
of E. coli competitor DNA (>I50 ^g/ml), approximately 10 times more Mhal 5' MAR 
remained bound compared to Adhl 5' MAR. Inhibition of Adh J 5' MAR binding by the 
addition of cold Mhal 5' MAR and vice-versa (Figure 5C) confirmed the relative strength 
of binding by each MAR: 50 ng/ml of cold Mhal 5' MAR completely abolished Ac/Ziy 5' 
MAR binding, whereas 50 ng/mi of cold Adhl 5' MAR left 9% of labeled Mhal 5' MAR 
bound to the matrices (Figure 5C). Because Adhl and Mhal 5' MARs can compete with 
one another in binding maize nuclear matrices, some of the components required for 
matrix binding of Adhl 5' MAR must also be involved in binding the Mhal 5' MAR. 
Figure 5. MAR Binding Assays. In all panels, vector and MAR fragments are labeled V 
and M, respectively. Labeled DNA, without binding matrices, is shown in 
lane i. 
A) Yeast ARS1 sequences bind maize matrices with a lower affinity than 
the vrmztAdhl 5' Mi^. In the presence of a 1000-fold molar excess of 
competitor DNA (100 ng/ml), 3% of yeast ARSl and 10% of the Adhl 5' 
MAR remained matrix-bound. 
B) The Mhal 5' MAR displayed the highest affinity for binding to the 
matrix. In the presence of a 1500-fold molar excess of competitor (150 ng/ 
ml), 30% of the Mhal 5'MAR remained bound, while under the same 
conditions, only 3.5% of Adhl 5' MAR remained bound. 
C) Binding of Mhal 5'MAR in the presence of different concentrations 
of £. coli DNA or 50 ng/ml of unlabeled Adhl 5' MAR (left panel). 9% of 
Mha] 5'MAR is still bound to the matrix in the presence of 50 ng/ml of 
unlabeled 5' MAR. When the binding of labeled Arf/i/ 5' MAR was 
challenged with different concentrations of unlabeled Mhal 5'MAR (right 
panel), 25 ng/ml of the specific competitor left only 3% of ih&Adhl 5' MAR 
bound to the matrix and 50 ng/ml of unlabeled Mhal 5'MAR completely 
abolished the matrix-binding of \hs,Adhl 5' MAR. 
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Figure 6. Effects of MARs on transient expression of 35S::luciferase. Five reps for each 
treatment were assayed for luciferase and GUS expression. 35S::Iuciferase 
vectors PHP1528, PHP5483 (ARSl), PHP6248 {Adhl), and PHP6486 {Mhal) 
were mixed 5:1 with 35S::GUS vector PHP264. Relative levels of gene 
expression were calculated by normalizing luciferase to the level of GUS 
expression. F-test indicated no significant difference between means (P=0.21). 
4.1.2 MAR elements do not affect expression prior to integration in maize BMS 
cultures 
Transient assays of reporter gene expression were used to test if each MAR has 
enhancer activity in BMS cells (Allen et al., 1993; Mlynarova et al., 1994; Poljak et al., 
1994; Allen et al., 1996). Since stably integrated transgenes flanked with MARs have often 
been shown to have higher levels of expression than unflanked transgenes, it is important 
to determine by transient assays how much of this increase in gene expression conferred 
by MARs is due to an enhancer effect that would be observed prior to integration. Figure 6 
compares the expression level of constructs in which 35S::luciferase was flanked by each 
of the three MARs studied with the control vector lacking MARs (PHP 1528). The 
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luciferase constructs being tested were introduced into BMS-S calli in combination with a 
fixed level of a 35S::GUS plasmid (PHP264), and luciferase expression was normalized to 
GUS expression. None of the three MAR elements we tested increased or decreased the 
expression level to a large extent compared to the control vector without MARs. Thus, 
none of the MARs appears to enhance the expression of unintegrated genes in vivo. 
4.1.3 Transgene expression levels in stable BMS transformants are bimodally 
distributed 
To facilitate the study of a large number of BMS transformants, we chose the BAR 
gene as a selectable marker and firefly luciferase (Luci) as a reporter. Luciferase is simple 
to assay and is measurable over a range of 5 orders of magnitude. 35S ::BAR and 
35S::luciferase genes were introduced in irans- on separate plasmids at a dosage (3.3 ng/ 
bombardment) that had been shown previously to produce an average copy number of 1-3 
transgenes per transformant (Drummond et al., 1991) B. Drummond, M. Ross, D. Bond, 
G. St. Clair and B. Bowen, unpublished data; Figure 4). In one treatment, neither the 
reporter nor selectable marker contained MARs, whereas, in the other treatment, both the 
reporter and selectable marker were flanked with one of the three MAR elements. 
Because of the enormous variation typically seen in plant transgene expression levels, 
it is common to do a log transformation of the data prior to analysis (Nap et al., 1993). 
Some transformation studies have reported expression level data that are normally distrib­
uted after log transformation (Mlynarova et al., 1994; Allen et al., 1996), whereas others 
have reported a non-log-normal distribution (Hobbs et al., 1990; Breyne et al., 1992). 
Analysis of variance and other statistical tests can be applied if the data are normal (or log-
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normal), but nonparametric statistical analyses must be applied, if the data cannot be nor­
malized by transformation. 
Figure 7 shows log-transformed luciferase expression level data among BMS calli 
transformed with each of the four vector combinations tested. When more than 50 events 
per treatment were analyzed, it became clear that transgene expression levels were bimod-
ally distributed; with lower sample sizes, the distribution was not significantly different 
from log-normal. This was true for all treatments including the controls lacking MAR ele­
ments. Because the data are not normally distributed, I could not use analysis of variance 
to compare treatments. 
4.1.4 MAR effects on transgene expression in vivo do not correlate with in vitro 
binding strength 
The ARSl MAR (Figure 7C) and \htAdhl 5' MAR (Figure 7D) each increased the 
average luciferase expression level by 5.8- and 26.8-fold, respectively, compared to the 
control (Figure 7A). The increase in the level of average expression was associated with a 
shift from the first peak of the bimodal graph to the second peak (compare Figure 7C and 
D with A). This shift from a majority of low expressing events to high expressing events 
was largely responsible for the increase in average expression because the overall range of 
expression levels was similar in all treatments. The Mhal 5' MAR data (Figure 7C) did 
not show this shift and increased average luciferase expression by only 1.5-fold compared 
to die control. Previously, Allen et al. (1996) showed that a MAR with greater affinity for 
matrix preparations was able to increase expression of transgenes to a greater extent than a 
more weakly binding MAR. However, my results show that although the Mhal 5' MAR 
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Figure 7. The plasmids shown were shot in trans, one with luciferase and the other with 
BAR. Transgene expression level distributions are shown in the histograms. 
The box above the histograms is an outlier box plot. The box represents the 
interquartile range, or the difference between the 25th and 75th quantiles. The 
"whiskers" represent the range (computed as 150% of the interquartile 
range). Points outside the whiskers are possible outliers. The vertical line 
inside the box represents the median, and the diamond represents the mean. 
The bracket underneath the box identifies the most dense 50% of all the 
observations. All treatments were bimodal and the shape of the distributions 
are similar for no-MARs and Mhal, indicating Mhal had no effect on 
expression. ARS1 and Adhl both increased the expression level and shifted 
the majority of expressing events to the higher-expressing peak of the 
bimodal distribution. 
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has a greater affinity for maize matrices than the Adhl 5' MAR, the Adhl 5' MAR signifi­
cantly increased transgene expression, whereas the Mhal 5' MAR had almost no effect. 
ARS 1, the weakest binding MAR of the three studied, was still able to increase average 
luciferase expression levels 5.8 fold. This was a significant increase, although not as great 
as the 24-fold increase that Allen et al. (1993) found for ARS 1 in tobacco. 
4.1.5 Adhl 5' MAR and ARSl prevent transgene silencing in BMS 
Because the histograms in Figure 7 only include data from expressing events, results 
were also displayed using the cumulative distribution function (cdO- This graphical 
method effectively summarizes all the data from both expressing and non-expressing 
events. The cdf graphs, shown in Figure 8, reveal that flanking luciferase with either the 
Adhl 5' MAR or ARSl increased the proportion of events that express the luciferase 
transgene, whereas flanking luciferase with the Mhal 5' MAR had no effect on the trans­
gene expression level distribution. 
Figure 9 displays the differences seen among the proportions of non-, low-, and high-
expressing events when the MAR-containing events were compared to the control. We 
divided events into low and high expressors by arbitrarily selecting a threshold between 
the two peaks of each bimodal distribution (Figure 7). The graph shows that ARS 1 and the 
Adhl 5' MAR more than doubled the number of high expressing events. ARS 1 increased 
the number of high expressing events primarily at the expense of the non-expressing 
events, whereas the Adhl 5' MAR nearly tripled the number of high expressing events at 
the expense of both non- and low-expressing events. In contrast, the Mhal 5' MAR had 
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Figure 8. Cumulative distribution function graphs. Ranking 35S::Iuciferase with either 
iheAdhl 5' MAR or ARSl resulted in a significantly different expression 
distribution, whereas flanking 35S::luciferase with the Mhal 5' MAR had no 
effect. 
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Figure 9. N-fold difference graph. Values indicate the n-fold difference from the control 
without MARs. Main effect of ARS1 and Adhl MARs is to increase the 
number of high expressing events. Mhal had no effect on expression levels. 
very little effect on the proponions of non-, low-, or high expressors compared to the con­
trol. Both ARS 1 and Adhl 5' MAR decreased the number of non-expressors approxi­
mately 2-fold, indicating that both of these MARs increase average expression by 
preventing transgene silencing. 
4.1.6 Discussion 
The results of this section are summarized in Table 4. The three MAR elements tested 
each had different binding affinities for maize nuclear proteins, representing an approxi­
mately 30-fold difference in binding strength. Allen et al. (1996) suggested that there is a 
correlation between MAR binding strength and the effects of MARs on transgene expres­
sion. They found that the tobacco Rb7 MAR, which has a greater affinity for tobacco 
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Table 4. Summary of Results. 
Relative Mean N-Fold N-Fold Increase 
Binding Expression Increase Over in High 
MAR Strength LeveJ" Control Expressors Range** 
no MAR N/A 8.0 I.OX N/A 11.24 
ARSl I 20.7 5.8X 2.4X 10.44 
Adhl 5' 3 214.9 26.8X 2.7X 11.17 
Mhal 5' 30 11.8 1.5X l.OX 11.52 
a. LU/|jg Protein 
b. 1.5 • interquartile range (same as whiskers in Figure 7) expressed as ln(max.)-ln(min.) in ln(LU/ 
Hg E^rotein) 
matrixes than the yeast ARS1 MAR, increased reporter gene expression 140-fold com­
pared to a 24-fold increase with ARSl. In this study, I found that the stronger binding 
MAR (Mhal 5' MAR) had no effect on reporter gene expression, but a weaker binding 
MAR {Adhl 5' MAR) increased the average transgene expression level by 26.8-fold and 
the likelihood of obtaining a high expressing event by 3-fold. In contrast to the suggestion 
made by Allen et al. (1996), I found no correlation between MAR binding strength and 
MAR effects on transgene expression in vivo. 
Both ARS 1 and the Adhl 5' MAR had similar effects on stable transgene expression 
distributions, but the Adhl 5' MAR had a greater effect on average transgene expression 
levels. Both MARs increased mean expression level in stable transformants but not in tran­
sient assays. Neither MAR appeared to reduce the range of expression (Table 4), indicat­
ing that position effects on transgene expression level variation were not affected. Both 
MARs increased the proportion of expressors at the expense of non-expressors, however, 
indicating that the main effect of each MAR was to decrease the likelihood of transgene 
silencing. One practical benefit suggested by our data, is that two to three times fewer 
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transformants might need to be generated and/or screened when a transgene is flaniced by 
either ARSl or thcAdhl 5' MAR. This conclusion was based on data obtained with a sin­
gle subculture of BMS (BMS-S) over a period of 12 months. Subsequent study of MAR 
effects with different transgenes and in different BMS subcultures made me modify these 
conclusions, as described more fully in the next section. 
Recent studies of the 5' and 3' MARs from the tomato Heat Shock Cognate 80 
{HSC80) gene suggest a possible reason for the differences observed for ihtAdhl and 
Mhal 5' MARs in our work (Chinn and Comai, 1996; Chinn et al., 1996). These studies 
indicated that the 5' and 3' MAR elements were essential for regulated expression, but 
only when combined with transgenes that harbored introns of HSC80. Absence of either 
MAR or any of the introns reduced or eliminated expression. All of my constructs used in 
this study contained the first intron of maiztAdhJ, because this element significantly 
enhances maize transgene expression (Callis et al., 1987). Thus, cooperation between fac­
tors bound by the Adhl 5' MAR and the Adhl first intron could be important for the Adhl 
5' MAR effect in vivo. In contrast, factors bound by the Mhal 5' MAR may not be com­
patible with factors bound by ihsAdhl intron. To explore this hypothesis further, it would 
be interesting to test die Mhal 5' MAR with other Mhal-denved sequences (e.g. introns) 
and \hcAdhl 5' MAR without the Adhl first intron. 
All three MARs bound maize nuclear matrix proteins in vitro, and some of the factors 
that bound the Adhl 5' MAR also bind the Mhal 5' MAR (Figure 5). However factors 
which bind both Adhl and Mhal 5' MARs in vitro are clearly not sufficient for the Adhl 
5' MAR effects in vivo. 
Yeast ARS I can bind to tobacco matrices in vitro and when used to flank transgenes in 
tobacco callus, raised transgene expression levels 24-fold (Allen et al., 1993). In collabo­
ration with Zoya Avramova, I have demonstrated that ARS 1 also binds maize matrices in 
vitro. In maize, however, ARS 1 had less of an effect on transgene expression levels than in 
tobacco. Yeast ARS 1 also had less of an effect on expression levels than an endogeous 
MAR which is consistent with the findings of Allen et al. (1996) in tobacco. If MAR ele­
ments participate in a regulatory role through the binding and action of various proteins, it 
might be expected that an endogenous MAR would bind these proteins more readily and 
thereby have a greater effect on the level of transgene activity. 
Do the maize Adhl 5' MAR and yeast ARS 1 prevent transgene silencing by acting as 
boundary elements? Boundary elements block neighboring control elements, such as 
enhancers or silencers, and prevent the spread of heterochromatin (Geyer, 1997). This 
should lead to copy number dependent and position independent expression. Several stud­
ies in plants have reported decreases in variation when flanking a reporter gene with MAR 
elements, suggesting limited boundary element function (Breyne et al., 1992; Mlynarova 
et al., 1994; van der Geest et al., 1994; Mlynarova et al., 1996), and in one case, partial 
copy number dependent expression (Schoffl et al., 1993). However, none of the MAR ele­
ments in these studies were completely able to overcome position effects. In my study, the 
maize Adhl 5' MAR and yeast ARS 1 had no effect at all on reducing position effects 
(Table 4). Although these MARs may prevent transgene silencing by impairing the estab­
lishment of heterochromatin or a repressed transcription state, they appear to have no abil­
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ity to block neighboring control elements such as silencers or enhancers. Thus, neither 
MAR has the properties of an insulating boundary element as defined by Geyer (1997). 
What could be responsible for the MAR effect in vivol One possibility is that MARs 
may create chromatin loops that are accessible to factors required for initiation of tran­
scription, but that the level of steady-state transcription is determined by nearby regulatory 
elements. Conversely, MARs may function as regulatory elements responsible for the tran­
sition from silent to active chromatin either through their inherent unwinding capability or 
by binding regulatory proteins that affect the likelihood that an active transcription state is 
established. This second possibility is consistent with the bimodal distribution of gene 
expression levels and the effect of MARs in shifting the expression level distribution in 
favor of high expressors. 
What are possible reasons for the bimodal distributions of the expression level data? 
Hobbs et al. (1990) reponed bimodal expression in tobacco transformed with GUS. They 
found that when transformed tobacco plants contained multiple copies of the transgene, 
the expression was much lower than in tobacco plants containing a single insert. Allen et 
al. (1996) reported that transgenic events containing greater than 10 copies had a greatly 
reduced expression level than events with less than 10 copies. The fact that multiple copies 
of a sequence in plants can trigger silencing has been well documented (Matzke and 
Matzke, 1995; Jorgensen et al., 1996; Wolffe, 1997). 
In my study, I was unable to complete Southern blot analysis of a large number of 
transformants to see if copy number differences could be responsible for the bimodal dis­
tribution. However, previous data indicates that more or less all BMS transformants 
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obtained with the dose of DNA used here were low copy (Figure 4). Another possible 
explanation could be differences in methylation. Many studies have found that silenced or 
low-expressing transgenes were methylated and high-expressing transgenes were unmeth-
ylated (Hobbs et al., 1990; Kilby et al., 1992; Tsanev et al., 1993). Differences in the level 
of transgene expression and/or methylation could reflect the chromosomal position of 
transgene integration. For example, transgenes integrated near telomeres, centromeres, or 
other hetrochromatic regions may be localized in transcriptionally inactive domains of the 
nucleus, close to the nuclear periphery, whereas transgenes integrated at other chromo­
somal positions may localize in transcriptionally active domains within the interior of the 
nucleus. Finally, it is also possible that there are differences intrinsic to cells when the 
transgene transcription state is established (Pillus and Rine, 1989; Loo and Rine, 1995). 
For example, the probability of transgene silencing may vary in different stages of the cell 
cycle (Loo and Rine, 1995). Some of these possibilities are addressed in the next section. 
4.2 Effects of MARs on Establishment and Heritability of Stable 
Transcription States Require Silencing Factors that are Lost in Aging 
Maize Cells 
4.2.1 Non-autonomous and synergistic effects oiAdhl 5' MAR on reduction in 
transgene silencing 
In section 4.1,1 showed that the Adhl 5' MAR had the greatest effect on transgene 
expression, so I decided to study the effects of this MAR in greater detail. Other studies of 
MAR elements in plants have flanked the reponer transgene, but not the selectable marker 
(Breyne et al., 1992; Allen et al., 1993; Allen et al., 1996). To compare my results with 
these studies, I tested combinations where one or the other or both transgenes were flanked 
with the Adhl 5' MAR. As shown in the previous section, flanking both luciferase and 
BAR with \htAdhl 5' MAR increased the average expression level significantly over that 
of the unflanked controls (Figure 10). However, flanking either luciferase or BAR alone 
also increased average luciferase expression levels above that of the control. These results 
indicate that theArf/i/ 5' MAR can increase the average expression level of 35S::luciferase 
non-autonomously, i.e. even when it is present on a separate vector in trans-. Additional 
copies of the Adhl 5' MAR flanking the BAR gene can apparently interact with MARs 
flanking luciferase and have a synergistic effect on luciferase expression. 
Since transgenes introduced on separate vectors typically integrate into a site together 
(Czemilofsky et al., 1986; Huang and Dennis, 1989), it is possible that an unflanked trans-
gene could become MAR-flanked by integrating between two MAR-flanked transgenes. 
While this could account for the effects seen when one transgene is flanked but not the 
other, it cannot easily account for the synergistic effect seen when both transgenes 
areflanked by MARs (Figure 10 and 11). Another possible explanation is that ihtAdhl 5' 
MAR can act as an enhancer of transcription. Thus, the MAR flanking one transgene in 
treatments 2 and 3 could enhance expression of both the flanked and unflanked genes. 
When both transgenes are flanked, the enhancer may act synergistically if cooperative 
binding of rran^-acting factors is affected by extra copies of the MAR. This explanation 
would be appealing, except for the fact that the Adhl 5' MAR had no enhancer activity in 
the transient assays reported in section 4.1. 
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Figure 10. Histograms oiAdhl 5' MAR in BMS-S. Treatments 1 and 4 were shown 
earlier comparing the effects of different MARs. In treatments 2 and 3, the 
effect of flanking one transgene with the MAR is midway between no 
flanking MARs and flanking both transgenes. 
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Figure 11. Cumulative distribution function graph of the data in Figure 10. AdhI 5' 
MAR flanking one transgene or the other results in distributions midway 
between those shown previously where both of the transgenes or neither of 
the transgenes were flanked by theAdhl 5' MAR. Numbers represent 
treatments shown in Figure 10. 
4.2.2 Adhl 5' MAR prevents transgene silencing by interacting with /ra/i^-acting 
silencing factors that disappear the longer the BMS cells have been maintained 
To determine if the effects of \htAdhl 5' MAR on transgene expression levels are an 
intrinsic property of the sequence and stable in different cell types, I compared the behav­
ior of 35S::luciferase flanked by this sequence in many replicated experiments using four 
different subcultures of BMS (BMS-S, BMS-S3, BMS-S4, and BMS-S5) that were sepa­
rated from the parent cell line at different intervals over a period of five years (Figure 3). 
Results are summarized in Figure 12. 
As described in section 4.1, the average expression level of luciferase was 26.8 fold 
higher for Adhl 5' MAR flanked events than the unflanked events in BMS-S. In BMS-S3 
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Figure 12. Histograms comparing BMS lines {otAdhl 5' MAR-flanked and non-MAR 
events. A non-MAR flanked plasmid (PHP1528) or a MAR-flanked plasmid 
(PHP6248) was transformed into each of the BMS lines. See Figure 7 for a 
description of the parts of the graph. A) In BMS-S there is a distinct 
bimodality to the distribution of expression with the majority of expressing 
events in the lower peak for non-MAR events and the upper peak for MAR 
events. B) In BMS-S3 the distribution is similar to BMS-S except for a large 
peak. C) In BMS-S4 the distribution has changed so that both non-MAR and 
MAR events have a similar distribution. However, in all BMS cell lines the 
MAR increases the average expression level (26.8-fold for BMS-S, 3.6-fold 
for BMS-S3 and 2-fold for BMS-S4). 
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\heAdhl 5' MAR increased average luciferase expression 3.6-fold (Figure 12B), and the 
distinction between the expression level distributions for MAR-flanked and control 
35S::luciferase was not as great as had been seen in BMS-S (Figure 12A). In BMS-S4, the 
AdhI 5' MAR conferred only a 2-fold increase in the average expression level and the 
expression level distributions were almost identical (Figure 12C). 
Figure 13 summarizes how the differences between non-MAR and MAR flanked 
events changed as BMS got older. Figure 13A shows how the MAR affected the propor­
tions of non-, low-, and high-expressors in each cell line, whereas Figure 13B contrasts the 
varying effects of the MAR on each expression class as a function of the cell-line subcul­
ture (see Figure 3). Clearly, the effect of the AdhI 5' MAR on reducing transgene silenc­
ing decreased progressively over time between BMS-S, BMS-S3 and BMS-S4 
(Figure 13A). Furthermore, the diminishing increase in high expressors over time was 
closely mirrored by smaller decreases in non-expressors and low expressors over time 
(Figure 13B). 
Figure 14 helps clarify why the initial effect of MARs on increasing high-expressors 
disappeared over time. The proportion of high expressors in events transformed with the 
control 35S::Iuciferase vector lacking MARs (PHP1528) increased in each cell line 
(BMS-S to BMS-S3 to BMS-S4), indicating that the level of silencing in each new cell 
line was less than in the previous one. At the same time the proportion of high-expressing 
events obtained with the MAR-flanked 35S;:luciferase vector (PHP6248) decreased. 
Hence, in BMS-S4, the proportions of non-, low- and high-expressors was essentially the 
same for events with or without flanking MARs. Figure 15 illustrates this in cdf format. 
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Figure 13. N-fold difference graphs of the differences in expression levels for three cell 
lines. A is grouped by cell line and B is grouped by expression level. 
Classification of non-, low- and high-expressing events was made in the same 
way as described in section 4.1.5. 
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Figure 14. Graph of the frequency of high-expressors for 35S::luciferase (PHP1528) 
and 35S::luciferase flanked with Adhl 5' MAR (PHP6248) in three BMS 
subcultures: BMS-S, BMS-S3, and BMS-S4. The high expressors were 
divided as described in Section 4.1.5. In each cell line the frequency of high 
expressing events increases for the non-flanked control, and decreases for the 
MAR-flanked luciferase events. 
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Figure 15. Cumulative distribution function graph comparing results for MAR-flanked 
and non-MAR events using luciferase as a reporter. For non-MAR events 
only those for BMS-S4 are displayed. All other non-MAR events overlap 
the distribution of non-MAR events in BMS-S4. For MAR-flanked events 
the distributions became more similar to that of the non-MAR events with 
each new cell line. 
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The cdf graphs show how the expression distribution of the MAR-flanked events changed 
in each cell line. The distribution for the MAR-flanked events in BMS-S shows the great 
est difference from the non-flanked events in BMS-S4. This difference decreases in BMS-
S3, and disappears for MAR-flanked events in BMS-S4. 
From these data, I conclude that the Adhl 5' MAR effect seen in BMS-S was not an 
intrinsic effect, i. e. the MAR effect must be the result of an interaction between the MAR 
sequence and trans-nciing factors in a given cell type. Because BMS-S, S3 and S4 are, in 
theory, genetically identical, the influence of the Adhl 5' MAR on transgene expression 
must be viewed as an epigenetic effect. Furthermore, the phenotypic outcome of flanking 
transgenes with this MAR is unstable over time because of a MAR by cell-type interac­
tion, and the effects of the Adhl 5' MAR would be predictable only when trans-acting 
variables in these sub-lines have been characterized in greater detail. Additional inferences 
that can be made are discussed further in Section 4.2.8. 
4.2.3 Adhl 5' MAR prevents silencing of luciferase, but not GUS 
To see if the Adhl 5' MAR effects on luciferase expression were generalizable, I 
decided to test whether another transgene was similarly affected. Recent repons have indi­
cated that P-glucuronidase {GUS) is susceptible to epigenetic silencing inside plant cells 
(Baulcombe and English, 1996; English et al., 1996), which encouraged me to investigate 
the effects of flanking 35S::GUS with the Adhl 5' MAR. These data are summarized in 
Figure 16. 
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Figure 16. Histograms comparing BMS lines for MAR-flanked and non-MAR events. A 
non-MAR flanked plasmid (PHP264) or a MAR-flanked plasmid (PHP7974) 
was transformed into eachi of the BMS lines. See figure 3 for a description of 
the parts of the graph. The shape of the distributions is approximately the 
same for MAR-flanked events in BMS-S (A) and BMS-S3 (B) except that 
the mean is higher. The distribution and the means are basically the same 
between the non-MAR and the MAR-flanked events in BMS-S3 (B). For 
BMS-S4 (C) the distributions and means are again almost the same, except 
now the shape of the distribution is less bimodal. 
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35S::GUS vectors +/- MARs were introduced into BMS-S, but because of technical 
difficulties, I was only able to obtain expression level data from the MAR flanked events 
(Figure 16A). The expression levels were bimodally distributed as seen with luciferase. In 
contrast to the distribution seen for 35S::luciferase flanked by MARs (Figure 12), how­
ever, there was a significant shift in expression towards the lower peak. This suggested that 
35S::GUS might be more susceptible to silencing in BMS-S than luciferase. 
In BMS-S3, a similar distribution was observed for the MAR flanked 35S::GUS events 
as was observed in BMS-S, except the mean 35S::GUS expression level increased approx­
imately 35-fold (Figure 16B). In contrast to 35S::luciferase, the average level of 35S::GUS 
expression was the same with or without flanking MARs. 
In BMS-S4, thtAdhJ 5' MAR still had no effect on GUS transgene expression, but 
there was also no longer as much of a marked bimodal expression distribution as was seen 
for the previous cell lines with GUS and all cell lines with luciferase (Figure 16C). In fact, 
the distribution of expression for the non-MAR events was no longer significantly differ­
ent from log-normal (Shapiro-Wilk test indicates a P value of 0.07). In addition to the sig­
nificant change in the shape of the expression distribution, there was also nearly a 100-fold 
increase in the average expression level compared to BMS-S3 and nearly a 3,500-fold 
increase compared to BMS-S. In contrast to the 140-fold increase in GUS expression seen 
by Allen et al. (1996) when comparing non-MAR and MAR-flanked events, I observed a 
difference of 3,500-fold in GUS expression levels between cell lines. The significant 
increase in the mean level of GUS expression over time (i.e. from BMS-S to BMS-S4) is 
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consistent with the idea that these cell lines exhibited a progressive loss of transgene 
silencing as they aged (Figure 14). 
It was clear that the Adhl 5' MAR had a different effect on 35S::GUS than 
35S:.iuciferase. Comparing Figure I2A and 16A, the MAR flanked luciferase events have 
a higher peak for the high expressing events and the MAR flanked GUS events have a 
higher peak for the low-expressing events. Similarly, the Adhl 5' MAR increased 
35S::luciferase average expression levels by 3.6-fold in BMS-S3, but had no effect on 
35S::GUS expression in this cell-line (compare Figure 12B with 16B). 
The data for each treatment in each cell line is bimodally distributed (except GUS in 
BMS-S4), so it was not possible to compare the data sets by analysis of variance. How­
ever, means of non-normal data are normally distributed (Steel and Torrie, 1980). By arbi­
trarily dividing the data for each cell line into three groups, the mean and standard 
deviation for each of the three groups of data was calculated. These data are shown in 
Figure 17 for luciferase and GUS treatments, with and without flanking MARs in each cell 
line. The difference in the means between non-MAR and MAR-flanked events for 
luciferase in BMS-S indicates that the MAR is able to prevent silencing of many of the 
events. The mean for the MAR-flanked luciferase events does not change significantly 
between the different BMS cell lines, but in BMS-S4 there is a significant increase in the 
mean expression of the non-MAR events. This suggests that in BMS-S4, luciferase was 
less susceptible to silencing. Similarly, in the GUS events the increase in average expres­
sion in each sucessive BMS cell line implies that there was successively less silencing in 
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Figure 17. Mean expression level for luciferase and GUS in each cell line. Combined 
results were divided into three random groups. The average of the three 
groups was graphed along with the standard deviation 
BMS-S3 and BMS-S4. In contrast to luciferase, (ticAdhl 5' MAR had no effect on mean 
GUS expression levels in any of the cell-lines. 
4.2.4 Transgene copy number can mimic Adhl 5' MAR effects on transgene 
silencing 
All of the experiments to this point had been done at a DNA concentration shown pre­
viously to give an average of one to two copies per genome (Drummond et al., 1991) and 
unpublished data. Figure 4). Many studies of MARs flanking transgenes have been done at 
a much higher copy number (Stief et al., 1989; Phi-Van et al., 1990; Allen et al., 1993; 
Allen et al., 1996) with some events having greater than 100 transgene copies per genome 
(Phi-Van et al., 1990; Allen et al., 1993). Allen et al. (1996) suggested that one effect of 
MARs elements may be to reduce the likelihood of homology-dependent gene silencing, 
which is a common epigenetic phenomenon seen in transgenic plants (Jorgensen, 1990; 
Matzke and Matzke, 1995). To determine whether the Adhl 5' MAR could also attenuate 
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the effects of homology-dependent gene silencing, I examined the effects of increasing the 
DNA dose by 100-fold compared to my standard DNA dose. The average transgene copy 
number at this DNA dose in BMS ranges from about 10 to 200 (B. Drummond, M. Ross, 
D. Bond, G. St. Clair and B. Bowen, unpublished). At each DNA dose, equal amounts of 
35S::GUS, 35S::luciferase, and 35S::BAR were introduced on separate vectors in trans-. In 
one set of treatments, all three genes were flanked by the Adhl 5' MAR, whereas in the 
control treatments, none of the genes were flanked by MARs. The results of this experi­
ment are shown in Figure 18. 
At the Ix DNA dose, expression level distributions for luciferase were very similar to 
those seen earlier in BMS-S (Figure 10 and 12), with the larger peak of the bimodal distri­
bution corresponding either to the low expressing events for the non-flanked events or to 
the high-expressors for theAdhl 5' MAR flanked events, respectively (Figure 18A). Sur­
prisingly, the lOOx DNA dose also increased the mean 35S::luciferase expression level, 
and at the high dose, the expression level distributions for MAR-flanked and non-flanked 
35S::luciferase showed less of a difference than at the low DNA dose.These data indicate 
that the net effect of increasing transgene dose in BMS-S3 was similar to the effect that the 
Adhl 5' MAR had on luciferase expression at Ix dose in BMS-S (compare Figure 12A 
and 18A). A similar type of shift was also seen when comparing 35S::GUS without MARs 
at the Ix verses lOOx DNA doses (Figure 18B). These results indicate that increasing 
transgene copy number decreases silencing of both 35S::luciferase and 35S::GUS in 
BMS-S3, which is contrary to many studies that have reported homology-dependent 
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Figure 18. Effect of transgene copy number on 35S::luciferase and 35S::GUS 
expression. 35S::luciferase and 35S::GUS +/- MARs were transformed into 
BMS-S3 together in trans- at Ix or lOOx the normal dose of DNA used for 
bombardment. The same events were assayed for both luciferase and GUS 
expression. Results from luciferase and GUS assays are shown in (A) and 
(B), respectively. 
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silencing associated with multiple copies of a transgene sequence (for reviews see: Jor-
gensen, 1990; Matzke and Matzke, 1995; Dorer, 1997). 
Combining 35S::luciferase and 35S\:GUS together in the same treatment also had an 
effect on the MAR by transgene interaction noted earlier in Section 4.2.3. When 35S:-.GUS 
was transformed into BMS without 35S::luciferase at Ix DNA dose, flanking MARs had 
no effect on expression (Figure 16). However, when MAR-flanked 35S::GUS was intro­
duced together with 35S::luciferase flanked by MARs, the mean level of GUS transgene 
expression was 8.8-fold higher than the control treatment without MARs (Figure 18). In 
contrast, the effect of introducing MAR-flanked 35S::GUS in trans- on the increase in 
mean expression mediated by flanking 35S::luciferase with MARs was negligible by com­
parison (Compare Figure 12A and 18A). The effect of MAR-flanked 35S::luciferase on 
MAR-flanked 35S::GUS seen here may be mechanistically similar to the synergistic effect 
of combining multiple MARs described in Section 4.2.1. 
4.2.5 IVansgene transcriptional states are established at the cellular level 
Figure 19 depicts the covariation in 35S::luciferase and 35:\GUS expression for the 
four treatments described in Section 4.2.4. The data show that the parameters responsible 
for establishing and maintaining the transcriptional state of each transgene exhibit a 
mutual dependence. If each introduced transgene has an independent probability of being 
turned on or off, then there should be four peaks in each of the graphs shown in Figure 19, 
that correspond to each of the possible outcomes (i. e. lowAow, low/high, high/low, or 
high/high expression respectively). At the Ix DNA dose, the majority of events without 
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Figure 19. Co-variation in 35S::luciferase and 35S::GUS expression +/- MARs at Ix and 
lOOx DNA dose. The same data presented in Figure 18 are graphed as 
nonparametric bivariate density plots of luciferase vs. GUS expression. 
Contours bound die data points according to their density. Beside each 
contour graph is a mesh plot diagram of the same data. Data for IX DNA 
dose are shown in (A) and lOOX DNA dose in (B). These graphs show that at 
Ix DNA dose, both transgenes tend to express at the same level. At the lOOx 
dose, the transgene copy number masks the effects of the flanking MARs 
seen at the Ix dose, and the mean level of luciferase low-expressors is raised 
about 150-fold. 
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MARs exhibit a low/low pattern of GC/5Auciferase expression (Figure I9A). When both 
transgenes are flanked by MARs, the majority of transformants exhibit either a low/low or 
a high/high pattern of Gi/S'/luciferase co-expression, and very few events exhibit high/low 
or low/high patterns. This indicates that the probability of each transgene being silenced is 
not independent, but must be determined by the epigenetic state of the cell at the time 
when transcriptional states are established. Ranking each transgene with MARs dramati­
cally increases the likelihood that an active transcriptional state is established, irrespective 
of the epigenetic state of the cell. This provides further evidence that MARs prevent trans­
gene silencing by interacting with factors that establish and/or maintain a transcriptionally 
silenced state. At the lOOx dose, the majority of events exhibit high/high or high/low GUS! 
luciferase co-expression, irrespective of flanking MARs (Figure 19B). Interestingly, the 
average level of luciferase expression in the "low" peak is about 150-fold higher with the 
lOOx dose than with the Ix dose (Compare Figure 19A and 19B). This has a net effect of 
compressing the bimodal distribution so that it looks almost normal (Figure 18). 
4.2.6 Adhl 5' MAR afliects the maintenance and/or heritability of transgene 
transcriptional states 
English and Baulcombe (1996) reported that silencing of GUS was correlated with 
methylation of sites in the GUS gene. To see whether DNA methylation was involved in 
the silencing of transgenes in EMS, I investigated the effects of S-adenosyl-L-homocys-
teine (SAH), a demethylating agent reported to have none of the toxic side effects of 5-
azacytidine (De Cabo et al., 1994; De Cabo et al., 1995). The data from these experiments 
were analyzed in two ways. Section 4.2.6.1 summarizes the analysis of pooled data 
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obtained with events from BMS-S3, S4 and S5, whereas in Section 4.2.6.2, the data from 
events obtained in each cell-line are analyzed separately. 
4.2.6.1 Effects of SAH on gene expression in cell lines •/+ MARs. 
Figure 20 shows the effect of SAH treatment over time on the expression level distri­
butions of 35S::luciferase and 25::gus with and without flanking MARs. The main effect 
of SAH on 35S::luciferase expression is to change the transgene expression level distribu­
tion from a bimodal distribution to a more normal type of distribution (Figure 20A). This 
effect is similar to the effect of increasing copy number in 35S::luciferase events (compare 
Figure 18A and 20A) and results mainly from a progressive increase in the mean expres­
sion level of the low-expressors in response to SAH. After two days on SAH, the differ­
ence between MAR-flanked and non-flanked 35S::luciferase expression seen at Day 0 
disappears. The effect of SAH on 35s::gus expression in the absence of MARs is similar 
to that seen for 35S:;luciferase (Figure 20B). In contrast to the trend observed with 
35S::luciferase, however, the MAR-flanked and non-flanked 25s::gus distributions 
started out looking more or less identical prior to SAH treatment, but then showed a big 
difference in response to SAH over time. The mean level of 35s::gus expression without 
MARs increased much more rapidly over time than the mean level seen among events 
expressing MAR-flanked 35s::gus (Figure 20B). This effect was mainly caused by the 
slower rate at which the MAR-flanked events that expressed gus at low levels were dere-
pressed by SAH. 
Figure 21 summarizes the different effects of SAH treatment on the mean expression 
levels of 35S::luciferase and 35s::gus with and wi±out flanking MARs. SAH clearly 
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Figure 20. Effect of S-adenosyl-L-homocysteine (SAH) on expression of 
35S::luciferase and 35s::gus -/+ MARs. Transformants were assayed at 
time zero and transferred to solid media containing 150 |iM SAH. Samples 
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Figure 21. Different effects of SAH on mean 35S::luciferase and 35s::gus expression 
levels -/+ MARs. Mean levels of expression are graphed as a function of the 
length of SAH treatment. In the upper two graphs, means are graphed on a 
logarithmic scale, whereas in the lower two graphs, means are plotted on a 
linear scale. 
derepresses silenced copies of both 35S::luciferase and 35S::GUS, and 35S::luciferase 
was derepressed by SAH at a much faster rate than 35S::GUS. However, silenced copies 
of 25S::GUS flanked by the Adhl 5' MAR are derepressed at a significantly lower rate 
than silent copies of non-flanked 35S::GUS, an effect which is not as clearly seen for 
35S::luciferase because of the difference between MAR-flanked and non-flanked 
35S::luciferase level prior to SAH treatment. The data reflect specific transgene by SAH 
and MAR by transgene by SAH interactions, but demonstrate that the Adhl 5' MAR can 
have an effect on the maintenance and/or heritability of stable transcriptional states in 
response to perturbations such as SAH treatment. Thus, the same MAR sequence can 
affect both establishment and maintenance or heritability of stable transcription states in 
vivo. 
4.2.6.2 Analysis of SAH effects on transformants obtained with BMS-S3, S4 and S5 
Figure 22 shows the results of treating different transformants with SAH when the data 
are broken out according to cell line of origin. Interpretations of the data are complicated 
by the small sample sizes for each cell line and by changes in the cell lines over time. 
Much of die variation in behavior among different cell-lines is apparent in the summary 
graphs of the N-fold differences in mean expression levels over time below each of the 
summary sets of histograms in Figure 22A-F. The GUS responses in BMS-S3 and the 
luciferase responses in BMS-S4 reflect the responses seen in the pooled data the closest 
(Figure 20). Figure 23 shows that, in general, the Adhl 5' MAR flanked transgenes (i.e. 
both 35S::GUS and 35S::luciferase) were less likely to be derepressed by the demethylat-
ing agent than those without MARs, although the results varied firom cell line to cell line. 
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Figure 22. Histograms of SAH results separated by cell line. 35S::Iuciferase in BMS-
S3 (A). 35S::GUS in BMS-S3 (B). (C) 35S::luciferase events in BMS-S4. 
D) 35S::GUS events in BMS-S4. E) 35S::luciferase events in BMS-S5. F) 
35S::GUS events in BMS-S5. Below the histograms is a N-fold difference 
graph of the means for the three treatment lengths. 
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Figure 23. N-fold difference in SAH treated events. Events from each of the above 
treatments were treated with SAH for 48 hours (2 days) and assayed. 
Expression levels were compared to the expression level before treatment. 
Randomly chosen events (n= 16-79) for each treatment from 3 different 
experiments in three different cell lines were grouped. 
resulting in large error-bars. This reflects the slower rates of derepression seen in the first 
two days of SAH treatment for the MAR-flanked events in the pooled data (Figure 21). 
Many studies have shown that treatment with the histone deacetylase inhibitor trichos-
tatin A (TSA) can also activate expression of silenced genes (Yoshida et al., 1995; Chen et 
al., 1997). To determine if histone acetylation could relieve silencing, I treated both 
35S::luciferase and 35S::G£/5 events in BMS-S5 withTSA. The results are shown in 
Figure 24. TSA appeared to have no ability to derepress either GUS or luciferase in this 
cell line, but this could be because the level of transgene silencing had akeady been low­
ered to such an extent to nullify any effects that might have been observed. 
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Figure 24. Effects of Trichostatin A (TSA) treatment on 35S::luciferase and 35s"gus 
expression. Events from BMS-S5 were treated with TSA for 24 hrs. and 
assayed. 
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4.2.7 ARSl effects on transgene expression also change in older BMS cells 
The 2x2 experiment design employed in section 4.2.1 was also used to investigate the 
effects of flanking one or both transgenes with ARS1. In contrast to the results obtained 
with the Adhl 5' MAR, the effect of flanking one transgene with ARSl on expression of 
an unflanked gene was strikingly different, at least in BMS-S. Figure 25 shows the results. 
As mentioned earlier, flanking both BAR and luciferase with ARSl (treatment 4) increased 
the average expression level over that of the control (treatment I) where no ARSl 
sequences were used. In contrast, when only one of the transgenes was flanked by ARSl, 
expression of the non-flanked transgene was apparently suppressed. For example, when 
BAR flanked by ARSl was introduced with 35S:;luciferase (treatment 2), the average 
luciferase expression level was near zero for all events analyzed. When 35S:.BAR was 
introduced with ARSl-flanked 35S::luciferase (treatment 3) no events were recovered, 
indicating that the selectable marker must not have been expressed at a high enough level 
to confer resistance to the herbicide used for selection. This experiment was repeated 
twice in BMS-S with the same results. 
Transgenes introduced on separate vectors typically co-integrate together at one or 
few integration sites (Czemilofsky et al., 1986; Huang and Dennis, 1989). My working 
model for the effects of ARS 1 seen in Figure 25 invokes the directionality that has been 
associated with insulator and/or silencer elements in yeast and Drosophila (Geyer and 
Corces, 1992; Cai and Levine, 1995). In this case, ARSl may prevent silencing of the 
transgene it flanks, but may actively promote silencing of non-MAR flanked DNA outside 
of the ARS I-bounded loop. To test this model, I designed and constructed vectors with the 
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selectable marker and reporter genes in cis-, where one or the other of the genes was 
flanked with ARS1. However, by the time I was ready to test these vectors, I was using 
BMS-S5 for transformation, which as shown earlier, exhibited significantly reduced levels 
of transgene silencing analogous to those seen in BMS-S4. Figure 26 compares the results 
of the 2 X 2 experimental design in BMS-S5 using the cis- and trans- vector combinations. 
In BMS-S5, the rra^^-combinations (treatments 2 and 3) did not have the same effect as 
they did in BMS-S and there was essentially no difference between the cis- and trans-
treatments (Figure 26). Thus, I was unable to determine if my model was correct because 
of the altered responses in BMS-S and BMS-S5. However, the differences seen between 
BMS-S and BMS-S5 are entirely consistent with the loss of transgene silencing inferred 
from experiments with the Adhl 5' MAR. 
4.2.8 Decreases in end-joining parallel loss of transgene silencing in aging EMS 
cells 
In stable transformants, transgenes integrate through the non-homologous double-
stranded break repair (DSBR) pathway. Non-homologous DSBR is the predominant path­
way for repairing double-stranded breaks in multicellular eukaryotes (e.g. humans, maize) 
(Fishel et al., 1991; Daza et al., 1996; Shalev and Levy, 1997). In yeast, die predominant 
pathway for DSBR is homologous recombination involving Rad51/52 mediated exchange. 
When the Rad51/52 dependent pathway is inactivated in yeast, however, DSBR occurs 
predominantly via an end-joining process. This involves a heterodimeric protein similar to 
the Ku antigen that binds dsDNA breaks in higher eukaryotic cells. One of the subunits of 
this complex, Hdfpl, has recently been shown to interact with silent information regulator 
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Figure 26. Histograms of ARSl data in BMS-S5. Treatments are essentially the same as 
for figure 12, except in the second set of four treatments the reporter and 
selectable marker were linked together on the same plasmid. 
92 
(SIR) proteins that are required for gene silencing in yeast (Tsukamoto et al., 1997). This 
suggests that for end-joining to occur, the chromatin must be in a heterochromatic state 
(Lustig, 1998). Besides promoting the loss of gene silencing and reducing the frequency 
of end-joining, mutations in sir2, sir3, and sir4 also decrease the lifespan of the cell 
(Kennedy et al., 1995; Kim et al., 1996; Smeal et al., 1996; Austriaco and Guarente, 1997; 
Kennedy et al., 1997). In fact, loss of SIR function and loss of silencing are key features 
associated with the onset of aging in yeast (Lustig, 1998). 
Through the course of my dissertation work, I observed progressive loss of transgene 
silencing the longer the BMS cells were maintained (Section 4.2.2). Also, because MAR 
effects on transgene expression are epigenetic in nature, it is likely that fran^-acting silenc­
ing factors could be involved. Could SIR orthologs present in maize cells be responsible? 
To investigate this idea further, I calculated the number of transformants I obtained per 
bombardment for each cell line. Because SIR proteins are involved in end-joining, the 
transformation efficiency should be a good indicator of the level of these proteins present 
in the cells. Figure 27 shows that the frequency of end-joining decreased from one BMS 
subculture to the next. 
4.2.9 Discussion 
In this section, I have demonstrated that MARs can influence the establishment and 
maintenance or heritability of transgene transcription states in BMS cells. I also showed 
that the degree of transgene silencing in BMS decreased progressively over a period of 
five years. This correlated with progressive loss of the protective effect of MARs against 
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Figure 27. Average number of transformants obtained per bombardment for each cell 
line. Average number of transformants per bombardment was calculated for 
all experiments for each cell line. As the cell line ages transformation 
efficiency decreases. Error bars represent standard error. 
transgene silencing, suggesting that trans-aciing factors responsible for both effects might 
have been gradually lost from each BMS line over time. My findings in BMS are very sim­
ilar to observations made in aging yeast cells, where SIR proteins that are responsible for 
establishment and heritability of gene silencing are lost or rendered functionally inactive 
over time. In yeast, SIR proteins also interact with the machinery responsible for non­
homologous recombination (i.e. end-joining), and loss of SIR function is associated with 
reduced end-joining. Similarly in BMS cultures, as transgene silencing was lost, the levels 
of end-joining (as measured by the frequency of stable transformation) also decreased. 
Thus, factors involved in cellular aging, transgene silencing, end-joining, and the in vivo 
effects of matrix attachment regions in higher eukaryotic cells such as BMS may be inter­
related, much as they are in yeast. Unfortunately, since the effects in BMS were observed 
over a 5-year period, when the culture had already been maintained for approximately 20 
years, it would be difficult to repeat these experiments. To test whether loss of transgene 
silencing and the protective effects of MARs was truly associated with plant cell age, a 
system would need to be developed where the number of cell divisions could be tracked 
(Kennedy et al., 1995), and, preferably, an enrichment procedure for old cells could be 
devised (Smeal et al., 1996). This type of system might be able to determine if the changes 
I saw in BMS are common symptoms of aging in plant cells, or if other factors that 
changed during the five year period of my dissertation were responcible. 
The Adh I 5' MAR effects on transgene expression are epigenetic in nature and were 
not stable over time, because they depend on how long the cell line was maintained in cul­
ture and its capacity for silencing. I have been able to separate four variables that interact 
to influence expression of transgenes in BMS cells: MAR elements, transgene coding 
sequence, cell-line, and transgene copy number. I also found that differeent MAR by 
transgene combinations affected the response to SAH treatment. Table 5 summarizes 
some of the interactions between these factors that I observed. 
MAR by transgene interaction. Flanking luciferase with Adhl 5' MAR prevented 
silencing of luciferase in BMS-S and BMS-S3 and increased the average expression level. 
This result is consistent with the most commonly observed effect of MARs in plant trans­
gene expression studies (Breyne et al., 1992; Allen et al., 1993; Schoffl et al., 1993; Mly-
narova et al., 1994; van der Geest et al., 1994; Mlynarova et al., 1995; Allen et al., 1996; 
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Table 5. Summary of interactions affecting transgene expression in BMS. 
Copy SAH 
Interactions MAR Transgene Cell-Line Number Response 
J X X 
2 X X 
3 X X X 
4 X X X 
5 X X X 
6 X X 
van der Geest and Hall, 1997). However, flanking 35S::GUS withAdhl 5' MAR had no 
effect on GUS expression levels in BMS-S3. My data suggest that silencing of GUS and 
luciferase may involve different mechanisms, because in one case (i.e. 35S::luciferase) 
silencing is overcome by flanking MARs, whereas in the other (i.e. 35S::GUS), MARs 
have little effect. However, as MAR copy number is increased, the likelihood of escaping 
from silencing is increased, even for 35S::GUS (Section 4.2.4), suggesting that the molec­
ular basis for MAR by transgene interactions may involve competition between silencing 
and anti-silencing factors in vivo. Studies have shown that GUS is susceptible to silencing 
and that silencing is associated with and maintained by methylation (Baulcombe and 
English, 1996; English et al., 1996). In BMS, luciferase could be silenced by a different 
mechanism (e.g. by changes in histone acetylation). Our data indicate that silenced trans-
genes may exhibit different rates of derepression in the presence of SAH, depending on 
the sequence of the transgene itself and whether it is flanked by MARs. This derepression 
could be the result of demethylation caused by the SAH treatment (if SAH action in BMS 
is the same as in mammalian cells (De Cabo et al., 1994; De Cabo et al., 1995)). Different 
rates of derepression may reflect either differentiated access to demethylation enzymes in 
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vivo or differential loss of silencing factors following inhibition of maintenance methyla-
tion by SAH. 
MAR by cell line interactions. The Adhl 5' MAR had the greatest effect on 
luciferase expression in BMS-S(Figure 12A and 13). In BMS-S3 and BMS-S4, the differ­
ence between luciferase with or without flanking MARs decreased. MAR by cell-type 
interactions have been reported previously in a mouse system. There, a HSP70.1 promoter 
driven reporter was stimulated by flanking MARs (referred to as SARs in their report) in 
mouse embryos but not in differentiated tissues (Thompson et al., 1994). In contrast to the 
mouse study, BMS cell lines which showed different MAR effects did not differentiate. 
The differences observed over time could reflect either the age of the cell culture of other 
changes in cellular metablolism that occured during the 5-year period of study. 
The Adhl 5' MAR prevented silencing of luciferase, but not GUS in BMS-S3. How­
ever, silencing was relieved in BMS-S4 which masked the MAR effect on luciferase 
expression. This is reflected by the increase in average gene expression for GUS treat­
ments with and without MARs in BMS-S3 and BMS-S4. In both treatments, GUS expres­
sion increased over 100-fold from BMS-S3 to BMS-S4. The average expression level 
among non-flanked luciferase events also increased, but not to the extent of the GUS 
events. However, the average expression of MAR flanked luciferase events did not 
increase between the cell lines. 
This loss of silencing in BMS is an epigenetic event that could be caused by the lengdi 
of time in culture. In yeast, the SIR proteins involved in derepression of telomeric silenc­
ing are also involved in non-homologous double strand DNA break repair. Homology 
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between yeast proteins involved in this pathway and mammalian proteins indicate that 
these proteins may be common to all eukaryotes (Maize also has Ku homologs: B. Bowen 
and P. Mahajan, personal communication). A good measure of the efficiency of non­
homologous recombination is transformation efficiency, since transgene integration 
requires the non-homologous double strand DNA break repair pathway for integration 
(Smih et al., 1995; Dellaire and Chartrand, 1998). The good correlation between the pro­
gressive decrease in silencing and transformation efficiency throughout the course of my 
experiments closely parallels the situation found for aging yeast cells. Thus, many of the 
MAR by cell-line interactions I observed most likely are the result of BMS showing 
changes over time, similar to aging in yeast. 
The unique effect of ARSl in BMS-S also changed between BMS cell lines. In BMS-
S, when only one of the transgenes was flanked, the non-flanked transgene appeared to be 
silenced (Figure 25). However when the experiment was repeated in BMS-S5, ARS1 did 
not have the same effect; the unflanked transgene expressed at normal levels (Figure 26). 
This change is probably due to differences between the cell lines in their ability to silence 
transgenes. If ARS I was responsible for silencing unflanked adjacent transgenes in BMS-
S, it is possible that the factors involved in that silencing were either not present or not as 
prevalent in the BMS-S5. This may be why neighboring transgenes were no longer 
silenced in the older cell-line. 
SAH response and MAR by transgene interactions. Mutant phenotypes have been 
observed frequently in cultured cell lines (DeMars, 1974; Siminovitch, 1976; Holliday et 
98 
al., 1996), but, in many cases changes in gene activity are due to epigenetic silencing ran-
ther than genetic mutations (Compere and Palmiter, 1981; Holliday et al., 1996). 
Silenced genes in cell-lines or differentiated tissues of multicellular organisms are fre­
quently methylated, and silencing may or may not be maintained by methylation. Of the 
cell lines tested with SAH, silencing was most active in BMS-S3. We found that, in BMS-
S3, treatment with SAH derepressed non-flanked 35S::GUS expression more than in other 
cell-lines. For luciferase there was no significant increase in expression for either MAR-
flanked or non-MAR events in BMS-S3. Nevertheless, in BMS-S4 and BMS-S5, the SAH 
treatment did increase luciferase expression, indicating that in these cell lines silenced 
copies of 35S::luciferase were methylated. Results with SAH in BMS-S4 and BMS-S5 
were much more variable than in BMS-S3, however, suggesting that the capacity for 
maintaining genes in a silenced state may also have changed over time. Larger sample 
sizes would have been needed to determine in more detail how the effect of SAH treatment 
varied in older cell lines. However, the analysis of the pooled data clearly indicates a MAR 
by transgene effect. 
MAR by transgene by copy-number interactions. In plants, multiple copies of a 
transgene usually result in silencing of the gene, via one or more poorly defined mecha­
nisms commonly referred to as homology-dependent silencing (Jorgensen, 1990; Matzke 
and Matzke, 1995; Dorer, 1997). In BMS-S3,1 found that increasing transgene copy num­
ber can increase expression levels in a manner similar to the effect oiAdhl 5' MAR. As 
mentioned previously, Adhl 5' MAR shifts expression from the lower peak to the upper 
peak of the bimodal curve (at least in BMS-S and BMS-S3)(Figure 12A and ISA). This 
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same type of shift in expression levels also occurred in the GUS treatments without MARs 
when the DNA dose was increased from Ix to lOOx (Figure 18B). 
One explanation for the higher expression levels seen at the lOOx DNA dose may be an 
interaction between the multiple copies of the transgenes that blocks silencing. However, 
this type of pairing has normally been associated in Drosophila with position effect varie­
gation (Dorer and Henikoff, 1997). Another possibility is that, in this cell line, limiting 
levels of silencing factors may be titrated by the high transgene copy number, thereby 
increasing the probability that at high copy number, some of the transgenes will be active. 
At the lOOx DNA dose, the effects of MARs on either luciferase or GUS expression 
was masked. The Adhl 5' MAR had no effect on expression of 35S::GUS when intro­
duced with a MAR-flanked 35S::BAR vector. However, when a MAR-flanked 
35S::luciferase vector was added in trans-, the MAR increased 35S::GUS expression for 
both the Ix and lOOx doses. The effect of MAR-flanked 35S::GC/S on 35S::luciferase 
expression was negligible by comparison. Because MARs flanking 35S::GUS only 
increased expression when introduced in combination with MAR-flanked 35S::BAR and 
MAR flanked 35S::luciferase and not with MAR-flanked 35S::BAR alone, interactions 
must be taking place between MARs in trans-, allowing the higher copy number of MARs 
to have an effect on 35S::GUS expression. This non-autonomous synergistic effect of 
MARs was seen also in the 2 x 2 experiment described in Section 4.2.1. 
In general, when luciferase and GUS are introduced together, both transgenes are 
either expressed or silenced (Figure 19). In BMS-S and BMS-S3 at least, the expression 
distribution for both transgenes was bimodal. The bimodality could arise if there are two 
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different states of the cell or "epitypes" at the time when stable transcription states are 
established (Pillus and Rine, 1989; Loo and Rine, 1995). Each cellular epitype appears to 
act on both transgenes simultaneously to determine their expression states. At the Ix DNA 
dose, flanking both transgenes with MARs increases the likelihood that both transgenes 
will be expressed, independent of the cellular epitype. Cellular epitypes could be dictated 
by cell lineage, by cell age or by the stage of the cell cycle. Flanking MARs may increase 
the threshold level of factors that may be required for silencing to be established. 
A recent study in Drosophila described a lacZ reporter under the control of a GAL4 
UAS that also contained a Polycomb response element (PRE) (Cavalli and Paro, 1998). 
This construct also contained the white gene as a selectable marker. Because of the PRE, 
white gene expression was weak and variegated. However, when the transcriptional activa­
tor GAL4 was induced from a separate construct driven by a heat shock promoter, the 
Polycomb group (PcG) complex was displaced, and both lacZ and the white gene were 
expressed. When GAL4 was induced in embryos, the active state persisted and was main­
tained through many mitoses during somatic development. When GAL4 was induced dur­
ing larval development, however, the derepression was temporary. This experiment 
illustrates how different epigenetic states of the cell determined by a balance of activating 
and silencing factors, can affect establishment and maintenance of stable gene expression 
patterns. In BMS cells, there may be a similar competition between activating and silenc­
ing factors that determine or establish the transcription state of an introduced transgene. 
On the one hand, activating factors that could interact with MARs might include proteins 
such as trithorax orthologs, transcriptional activators, or histone acetylases, whereas, on 
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the other hand, silencing proteins could include polycomb or SIR orthologs and histone 
deacetylases. 
4.3 Other MAR Experiments 
In previous sections of this chapter, I described various factors that influence expres­
sion of transgenes in BMS cells. In this section, I describe a variety of experiments that 
attempted to address other factors that might influence the efficiency of transformation. 
These include the effects of linking the selectable marker and reporter on the same plas-
mid, linearizing the plasmids prior to transformation, alternately flanking the reporter and/ 
or the selectable marker with a MAR element, and changing the distance between the 
flanking MAR elements. Finally, I describe two unrelated experiments, one of which 
attempted to more precisely determine the sequences responsible for \heAdhl 5' MAR 
effects on transgene expression. The other experiment demonstrates the accessibility of 
the Adhl 5' MAR to rran^-activating factors in vivo. 
4.3.1 Linking the selectable marker and reporter 
Transformations using T-DNA and Agrobacterium obviously will have the selectable 
marker and reporter genes linked after integration into the genome. This is also the case 
for direct DNA transfer by particle gun bombardment. When a selectable marker and a 
reporter gene are on separate plasmids, both genes are typically linked after integration 
(Czemilofsky et al., 1986; Huang and Dennis, 1989). Because of this, I wanted to compare 
MAR-flanked and unflanked vectors, where the reporter and selectable maker were either 
on separate plasmids or in cis- on the same plasmid. 
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Figure 28 shows the vectors used and the results of the stable transformations with 
those vectors. Three comparisons were made, each in a different line of BMS. Figure 28 A 
shows a comparison for ARS1-containing vectors. The histogram on the left summarizes 
expression level data obtained when the reporter (luciferase) and the selectable marker 
(BAR) were shot on separate plasmids. The histogram on the right summarizes data 
obtained with luciferase and BAR linked together in cis- and flanked with ARS 1. 
Figure 28B is analogous to Figure 28A, except (hat Adhl 5' MAR was used instead of 
ARSl flanking the transgenes, and BMS-S3 was used as the cell line. In Figure 28C, the 
downstream 5' MAR was replaced with the Adhl 3' MAR. Figure 28D summarizes 
data obtained from unflanked transgenes introduced in cis- or trans- in BMS-S5. 
Because of changes in the cell lines, it is difficult to make general conclusions from 
these data. For ARSl, there was essentially no change between introducing the transgenes 
in cis- or in trans- in BMS-S (Figure 28A). This means that the plasmids in trans- most 
likely form concatamers upon integration and therefore behave similarly to the plasmid 
where both transgenes are already linked in cis-. However, the unflanked transgenes and 
the Adhl MAR flanked transgenes displayed a much higher average expression level in 
BMS-S3 or BMS-S5 when introduced in cis- (Figure 28B-D). This effect is possibly 
caused by the proximity of two 35S enhancer sequences adjacent to 35S::luciferase in the 
c/j-vector. If this is the case, however, then ARSl may suppress this effect, in contrast to 
[he Adhl MARs. 
These conflicting results are also confounded by the different degrees of transgene 
silencing in each cell line. In BMS-S, 35S::luciferase may have been more susceptible to 
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Figure 28. Comparison of co-transformation of transgenes in cis- vs. trans-. Luciferase 
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digesting with A/wNI, wliich cuts once in the vector backbone. All assays 
were done on the single-well luminometer except for those in BMS-S5 (D) 
which were assayed on the multiwell luminometer. 
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Figure 28. continued 
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silencing than in the other two cell lines. In this case, having the two genes linked would 
make little difference. However, in BMS-S3 and BMS-S5, if 35S::luciferase was less sus­
ceptible to silencing, then expression of ihe selectable marker in cis- may serve to keep the 
chromatin domain open and active, which could increase average levels of 35S::luciferase 
expression. 
4.3.2 Linearized vectors 
In several experiments, I tried linearizing the plasmids before bombardment. Because 
the transgene can occupy a significant proportion of the plasmid, there is a high likelihood 
that the breakpoint required for integration will occur within the transgene and interrupt its 
expression. In an attempt to increase the likelihood of recombination occurring outside the 
transgene, plasmids were linearized at restriction sites that fall outside of the transgene 
prior to transformation. 
All experiments with linearized plasmids were done in BMS-S3. Figure 29 shows the 
results for two comparisons of circular versus flanked plasmids. In both cases, linearizing 
the vectors resulted in a reduction of the average level of expression. Although linearizing 
the vectors may have increased the chances that recombination took place at the ends of 
the linearized plasmid, it probably also increased the chances that the DNA was degraded 
after it entered the cell. Linearizing the DNA could also have made the DNA more suscep­
tible to damage such as shearing. When particles are prepared for bombardment, the DNA 
is sonicated along with the tungsten beads. Thus, degradation of the DNA after entering 
the cell and shearing during particle preparation may each have contributed to the 
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observed decrease in expression levels. Another possibility is that supercoiling of the tem­
plate prior to integration helps the MARs exert their effect on establishing the transgene 
transcription state. 
4.3.3 Distance between MARs 
Another experiment that was done using linearized vectors examined the effect of 
increasing the distance between the flanking MARs. The distance between MARs in 
native chromatin typically varies between 5 kb and 200 kb. However, active genes are 
most frequently found in the smaller loops under 10 kb (Gasser and Laemmli, 1987). To 
test the effect of increasing the distance between the MAR elements, I inserted regions of 
lambda DNA between the pin II terminator and the MAR downstream of the transgene. 
The distance between the MARs in PHP6248 is approximately 3.6 kb. The two vectors 
containing lambda DNA increased the distance between the MARs to 6.5 kb in one 
(PHP8119) and 8.9 kb in the other (PHPI3328). Increasing the distance between MARs 
beyond 8.9 kb made the plasmids too unstable in the strains of E. coli I had available. 
Figure 30 shows that the effect of increasing the distance between the MARs was neg­
ligible. The 6.5 kb loop increased the average expression a small amount, but the increase 
was not significant. The 8.9 kb loop resulted in a decrease in the average expression. It is 
likely that this decrease was due to the factors mentioned previously that would affect lin­
earized plasmids (i.e. higher susceptibility to degradation inside the cell and higher sus­
ceptibility to shearing during preparation for transformation). Even without these factors, 
it is likely that these constructs would have had few differences in their effect. Natural 
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Figure 30. Results from increasing distance between MAR elements. The distance 
between MAR elements was increased by adding lambda DNA after the 
terminator and before the 3' MAR. 
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loop sizes in chromatin vary from 5 to 200 kb, a 40-fold difference. The increase from 3.6 
kb to 8.9 kb is only 2.5-fold and still is not over the 10 kb size, where less active genes are 
thought to be found (Gasser and Laemmli, 1987). 
4.3.4 \reAdhl 5' MAR effects on transgene expression conferred by 
transposable elements or by flanking sequences? 
The Adhl 5' MAR contains two transposable elements, one inserted inside the other, 
that make up nearly half of the MAR sequence (Avramova et al., 1998; Zoya Avramova 
and Alex Tikhonov, personal communication). These sequences have a high degree of 
homology to miniature inverted-repeat transposable elements (MITEs) (Figure 31). 
Another example of a MAR containing transposons is the transformation booster 
sequence (TBS) from Petunia hybrida. This sequence, which can increase transformation 
frequencies in petunia, tobacco, and maize, contains a MAR element that has strong 
homologies to a variety of retroviral elements (Galliano et al., 1995). Martienssen (1996; 
1998) and Matzke et al. (1996) have speculated that transposons play a role in gene silenc­
ing and imprinting phenomena in plants. In an attempt to determine if the MITEs in the 
Adhl 5' MAR were responsible for their effects in BMS, I constructed 35S::luciferase 
vectors flanked by fragments derived from the Adhl 5' MAR that either span the MITEs or 
the flanking sequence (Figure 31). Because the MITE region is about half the length of the 
Adhl 5' MAR, I doubled up the isolated MITE region to approximate the original MAR's 
length (Figure 2T-U). I also did the same for the vector flanked by non-MITE region of the 
Adhl 5' MAR (Figure 2V-W). The results of introducing these vectors into BMS-S5 are 
shown in Figure 32. 
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Figure 31. Map of the 5' region showing the locations of MITEs. Regions with 
homology to previously discovered MITEs are indicated (Bureau and 
Wessler, 1992). The region from -1201 to -680 was used for the MITEs 
containing vectors and from -680 to -243 was used for the non-MITEs 
vectors. 
There did not appear to be any significant difference between the 2xMITE" and the 
2xMITE'^ vectors. The average expression levels were essentially the same. Unfortunately, 
in BMS-S5, ihtAdhl 5' MAR had no effect on transgene expression levels, so it is diffi­
cult to make any conclusion regarding the lack of effect with the 2xMITE* and 2xMITE''" 
vectors. If this experiment had been done earlier, when transgene silencing was more prev­
alent, it is possible I could have elucidated whether the sequences responsible for prevent­
ing transgene silencing in the AdhI 5' MAR resided within the MITEs or in the flanking 
sequences. 
4.3.5 The AdhI 5' MAR is accessible to dam methylase 
Dam methylase is a prokaryotic enzyme that methylates the adenine in the sequence 
GATC (Brooks et al., 1983). When introduced into yeast, dam methylase preferentially 
methylates its recognition sequence in active chromatin (Hoekstra and Malone, 1985; 
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Figure 32. Attempt to determine if Adhl 5' MAR effects can be localized to MITEs. 
See text for more details of the experiment. There is essentially no 
difference in the mean expression levels between the 2xMITE" (PHP 13396) 
and 2xMITE'*" (PHP 13394) vectors in BMS-S5. It is possible that there 
would be a difference in cell lines with greater silencing potential, such as 
BMS-S. 
Singh and Klar, 1992). Inactive chromatin is inaccessible to the enzyme. Because I wanted 
to determine if \h&Adhl 5' MAR was accessible to soluble factors inside the nucleus of 
BMS cells, I transformed BMS with dam methylase. To control expression of dam methy-
lase in BMS, which I discovered was lethal (data not shown), I used an inducible system 
developed by Roth et al. (in prep.,see Section 3.6). After inducing dam methylase in BMS, 
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DNA was cut with the methylation sensitive isoschizomers Dpnl, Dpnll, and Sau3A and 
probed with the Adhl 5' MAR. A Southern blot of the results is shown in Figure 33. In the 
absence of dam induction, the Adhl 5' MAR hybridizes with high molecular weight DNA 
in both the uncut lane and the Dpnl lane, indicating that the GATC sequences near the 
Adhl 5' MAR are not normally methylated in BMS. In the Dpnll and Sau3A lanes, the 
Adhl 5' MAR probe hybridizes with a low molecular weight band, indicating that the 
DNA was purified adequately for restriction enzyme digestion. In the DNA extracted after 
dam induction, ihe Adhl 5' MAR probe hybridizes with a low molecular weight band in 
the Dpnl lane, indicating that dam methylase was able to methylate the Adhl 5' MAR 
region in vivo. This indicates that the Adhl 5' MAR must reside in open chromatin, which 
is consistent with the idea that the Adhl 5' MAR interacts with trans-acting factors in vivo. 
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Figure 33. Southern showing accessibility of Adhl 5' MAR to dam methylase. A) 
Autoradiograph of Southern blot. Lane I is uncut DNA, lane 2 is DpnU 
digest (cuts unmethylated GATC), lane 3 is Dpnl digest (cuts only 
methylated GATC), and lane 4 is Sau3Al digest (cuts regardless of 
methylation of GATC). When dam methylation is induced, a band appears 
in lane 3 indicating that the sites surrounding the Adhl 5' MAR were 
methylated. B) Restriction map of the maxzt Adhl gene, including the 5' 
MAR. Asterisks mark SaM3AI sites; numbers in parentheses represent 
nucleotides and hatched arrows indicate exons. 
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CHAPTER V. GENERAL CONCLUSIONS 
5.1 Conclusions 
Conservation of MAR properties between closely and distantly related species suggest 
that they must be an important component of the chromatin structure. The maize genome 
is highly repetitive, and all single copy regions studied so far are flanked by MAR ele­
ments (Avramova et al., 1995). Additionally, the placement of MAR elements is highly 
conserved. ThcAdhl regions of maize and sorghum show near identity in the order of 
genes and the placement of MAR elements flanking those genes (Avramova et al., 1998). 
This is true even though the sequences of the MARs are poorly conserved between the two 
species. Therefore the function of the MARs must be important. Also, if MARs were not 
important for the function of the genome, they would not be present so universally in 
eukaryotic cells. 
Although the presence and location of MAR elements is conserved, I still can not state 
precisely what their function is. In my work on MARs, I have found that: 1) different 
MARs can have different effects on establishing transgene expression states which carmot 
necessarily be predicted from their in vitro properties (Section 4.1); 2) that the same MAR 
element can have different effects depending on the age of the cell line it is introduced into 
(Section 4.2); 3) one role of MARs may be to maintain stable patterns of transgene expres­
sion, either silent or expressed (Section 4.2); and 4) MARs can even have a silencing 
effect on the chromatin outside the gene they flank (Section 4.2). 
rniually, I wanted to find out if MARs could insulate a transgene firom position effects 
and increase the likelihood of obtaining a transgenic plant with a transgene expressing at 
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an optimum level. To test this, I decided to use a BMS callus system where I could analyze 
a large number of events. Then, using the data from callus, I hoped I could apply that 
knowledge to plants. The prognosis, however, is more complicated than just flanking your 
favorite gene with a good MAR element and transforming it into maize plants. My data 
has shown that a better understanding is needed of the context of the genome that our 
transgenes are introduced into. In particular, we need to know more about why the genome 
is arranged the way it is. We know that MARs flank endogenous genes, but why and how 
particular combinations of MARs allow genes to function properly in vivo is still unclear. 
Although I found that the Adhl 5' MAR can influence whether a transgene is active or 
silent, and if it stays that way, this seems to be the result of many interacting factors, and 
not some intrinsic property of the MAR sequence per se. MARs may not function to insu­
late genes but to signal various regulatory elements that a gene is nearby. In this way, per­
haps, they help guide the proper proteins into position for ensuring appropriate gene 
regulation. Other studies have also shown that additional DNA sequences that interact 
with MARs are often required for proper transgene expression (Bonifer et al., 1994; Yu et 
al., 1994; Chinn and Comai, 1996; Huber et al., 1996). 
If I had more time, there are still some experiments I would like to have done. Because 
I found that the effect of \hQAdhl 5' MAR differed in the various cell lines, it would have 
been interesting to see if the Mhal 5' MAR would have had an effect in one of the other 
BMS lines. It is possible, for example, that as the effect of \he.Adhl 5' MAR decreased in 
older BMS cells, the Mhal 5' MAR might have started to have an effect. This would have 
provided more evidence that MARs may both mediate and respond to different epigenetic 
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states. It would also be interesting to test if the Mhal 5' MAR could have an effect on the 
expression of GUS. Because there appears to be a MAR by transgene interaction, perhaps 
the Mhal 5' MAR could increase the average expression of GUS. 
5.2 Application 
MAR elements will not be useful in future transgene studies, unless the context in 
which they are to be used is understood. My results have indicated that there are MAR by 
transgene interactions, so MARs and transgenes must first be tested empirically to see if 
they function well together. As indicated earlier, other studies have demonstrated that 
additional elements may be required for proper transgene expression (Bonifer et al., 1994; 
Yu et al., 1994; Chinn and Comai, 1996; Huber et al., 1996). It will be important in studies 
of MARs in whole plants to determine when and where the MAR element has an effect. 
Typically, matrices and MARs have been isolated from leaf tissue. MARs selected in this 
way may have stronger effects on transgene expression in leaves than in other tissues. 
More molecular studies such as those by Avramova et al. (1996) on the make up of 
natural chromatin and new microscopic studies showing the location and movement of 
DNA, RNA and proteins in the nucleus (see review Lamond and Eamshaw, 1998) are 
needed to understand how genes function in the nucleus. When we have identified the fac­
tors that are important to gene expression, then we can better mimic them when we try to 
introduce transgenes. 
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